Medical devices and methods for delivering cardiac pacing pulses
By introducing a bypass circuit into the high-voltage output circuit, the high operating current section is bypassed, enabling efficient delivery of cardiac pacing pulses by high-surface-area, low-impedance electrodes. This solves the problem of high current consumption, extends device life, and improves cardiac capture efficiency.
Patent Information
- Application Number
- CN202380024858.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-04
- Filing Date
- 2023-02-24
- Publication Date
- 2024-11-15
AI Technical Summary
Existing medical devices require high operating current in their high-voltage output circuits with high-surface-area, low-impedance electrodes when delivering cardiac pacing pulses. This results in excessive current consumption, affecting device lifespan and making it difficult to efficiently deliver low-voltage cardiac pacing pulses.
By introducing a bypass circuit in the high-voltage output circuit, bypassing the high-operating-current section, and using high-surface-area, low-impedance electrodes to deliver cardiac pacing pulses, another part of the high-voltage output circuit is used to deliver CV/DF shocks, reducing current consumption.
It effectively reduces the current consumption of the high-voltage output circuit, extends the device life, and can efficiently deliver low-voltage cardiac pacing pulses, improving cardiac capture efficiency.
Smart Images

Figure CN118973662A_ABST
Abstract
Description
Technical Field
[0001] The present disclosure generally relates to a medical device and method for delivering cardiac pacing pulses. Background Art
[0002] Medical devices can sense electrophysiological signals from the heart, brain, nerves, muscles, or other tissues. Such devices can be implantable and wearable or external devices that use implantable and / or surface (skin) electrodes to sense electrophysiological signals. In some cases, such devices can be configured to deliver treatment based on sensed electrophysiological signals. For example, implantable or external cardiac pacemakers, cardioverter-defibrillators, cardiac monitors, etc. sense cardiac electrical signals from the patient's heart. Medical devices can sense cardiac electrical signals from the heart and use electrodes to deliver electrical stimulation therapy to the heart, such as cardiac pacing pulses and / or cardioversion or defibrillation (CV / DF) shocks, which can be carried by medical electrical leads extending from the medical device to position the electrodes in or near the patient's heart.
[0003] A pacemaker or cardioverter-defibrillator can deliver therapeutic electrical stimulation to the heart via electrodes carried by one or more medical electrical leads coupled to the medical device. Cardiac signals sensed from the heart can be analyzed to detect abnormal rhythms. Upon detection of abnormal rhythms such as bradycardia, tachycardia, or fibrillation, one or more appropriate electrical stimulation pulses can be delivered to restore or maintain a more normal rhythm of the heart. For example, an implantable cardioverter-defibrillator (ICD) can deliver bradycardia pacing pulses to the patient's heart in the absence of a sensed intrinsic myocardial depolarization signal (e.g., R wave), deliver anti-tachycardia pacing pulses in response to detection of tachycardia, or deliver CV / DF shocks to the heart when tachycardia or fibrillation is detected. Summary of the invention
[0004] In general, the present disclosure relates to a medical device and technology for delivering cardiac pacing pulses using high surface area, low impedance electrodes. The medical device can be a pacemaker or an ICD configured to deliver cardiac pacing pulses using extracardiac electrodes (e.g., electrodes carried by non-transvenous leads or transvenous leads positioned at an extracardiac location). A medical device operating according to the technology disclosed herein can generate cardiac pacing pulses that can be delivered via a high surface area, low impedance electrode vector by delivering pacing pulses via a high voltage output circuit, the high voltage output circuit comprising a first switching circuit for delivering a high voltage CV / DF shock, the first switching circuit being bypassed to deliver the pacing pulses. The high voltage output circuit includes a second switching circuit to provide a return path for the CV / DF shock or cardiac pacing pulse delivered via the high surface area, low impedance electrode. The first switching circuit and the second switching circuit of the output circuit can be enabled during the delivery of the high voltage CV / DF shock pulse.
[0005] The first switch circuit can be disabled by control circuitry of the medical device and bypassed during delivery of a cardiac pacing pulse by enabling a bypass circuit that couples a cardiac pacing voltage source to a portion of the high voltage output circuit. In some examples, the medical device can deliver a CV / DF shock using the same high surface area, low impedance electrode vector used to deliver the cardiac pacing pulse by charging a high voltage holding capacitor used to deliver the CV / DF shock via the high voltage output circuit via an output path (which includes the first switch circuit) that is different from the cardiac pacing output path (which excludes the first switch circuit).
[0006] In one example, the present disclosure provides a medical device, which includes a high voltage therapy circuit, a cardiac pacing voltage source, and a bypass circuit. The high voltage therapy circuit includes: a high voltage capacitor, which is chargeable to a shock voltage amplitude; a high voltage charging circuit, which is configured to charge the high voltage capacitor to the shock voltage amplitude to generate a cardioversion / defibrillation shock pulse; and a high voltage output circuit, which includes a first part and a second part, the first part is configured to couple the high voltage capacitor to a first electrode terminal, and the second part is configured to couple the high voltage capacitor to a second electrode terminal, and the first part and the second part are used to deliver the cardioversion / defibrillation shock pulse. The cardiac pacing voltage source is configured to generate a cardiac pacing pulse signal with a pacing voltage amplitude less than the shock voltage amplitude. The bypass circuit is configured to couple the cardiac pacing voltage source to a cardiac pacing output path, which excludes the first part of the high voltage output circuit and includes the second part of the high voltage output circuit to deliver the cardiac pacing pulse signal via the first electrode terminal and the second electrode terminal.
[0007] In another example, the present disclosure provides a method, the method including generating a cardiac pacing pulse signal through a cardiac pacing voltage source of a therapy delivery circuit of a medical device, and enabling a bypass circuit of the medical device to couple the cardiac pacing voltage source to a cardiac pacing output path. The cardiac pacing output path excludes a first portion of a high voltage output circuit of the therapy delivery circuit, the first portion being configured to couple a high voltage capacitor of the therapy delivery circuit to a first electrode terminal to deliver a cardioversion / defibrillation shock pulse. The cardiac pacing output path includes a second portion of the high voltage output circuit, the second portion being configured to couple the high voltage capacitor to a second electrode terminal to deliver a cardioversion / defibrillation shock pulse. The method further includes delivering the cardiac pacing pulse signal via the first electrode terminal and the second electrode terminal.
[0008] In yet another example, the present disclosure provides a non-transitory computer-readable medium storing a set of instructions that, when executed by a control circuit of a medical device, causes the medical device to generate a cardiac pacing pulse signal through a cardiac pacing voltage source of a therapy delivery circuit of the medical device, and enables a bypass circuit of the medical device to couple the cardiac pacing voltage source to a cardiac pacing output path. The cardiac pacing output path excludes a first portion of a high-voltage output circuit of the therapy delivery circuit, the first portion being configured to couple a high-voltage capacitor of the therapy delivery circuit to a first electrode terminal to deliver a cardioversion / defibrillation shock pulse. The cardiac pacing output path includes a second portion of the high-voltage output circuit, the second portion being configured to couple a high-voltage capacitor to a second electrode terminal to deliver a cardioversion / defibrillation shock pulse. The instructions further cause the medical device to deliver the cardiac pacing pulse signal via the first electrode terminal and the second electrode terminal.
[0009] The present invention also discloses the following embodiments:
[0010] Embodiment 1. A medical device including a therapy delivery circuit, the medical device including a high voltage therapy circuit, the high voltage therapy circuit including a high voltage capacitor, a high voltage charging circuit and a high voltage output circuit. The high voltage capacitor is chargeable to a shock voltage amplitude. The high voltage charging circuit is configured to charge the high voltage capacitor to the shock voltage amplitude to generate a cardioversion / defibrillation shock pulse. The high voltage output circuit includes a first part and a second part, the first part is configured to couple the high voltage capacitor to a first electrode terminal, the second part is configured to couple the high voltage capacitor to a second electrode terminal, and the first part and the second part are used to deliver a cardioversion / defibrillation shock pulse. The therapy delivery circuit further includes a cardiac pacing voltage source, the cardiac pacing voltage source is configured to generate a cardiac pacing pulse signal having a pacing voltage amplitude less than the shock voltage amplitude.
[0011] The therapy delivery circuit further includes a bypass circuit configured to couple a cardiac pacing voltage source to a cardiac pacing output path that excludes a first portion of the high voltage output circuit and includes a second portion of the high voltage output circuit to deliver a cardiac pacing pulse signal via the first electrode terminal and the second electrode terminal.
[0012] Embodiment 2. The medical device according to embodiment 1, further comprising:
[0013] a sensing circuit configured to sense at least one cardiac signal;
[0014] and a control circuit that communicates with the sensing circuit and the therapy delivery circuit, the control circuit being configured to determine a need for cardiac pacing based on at least one cardiac signal, and in response to determining the need for cardiac pacing, control the therapy delivery circuit to deliver a cardiac pacing pulse signal by enabling the bypass circuit to couple a cardiac pacing voltage source to the cardiac pacing output path.
[0015] Embodiment 3. A medical device according to any one of embodiments 1 to 2, wherein a first portion of the high voltage output circuit includes a first high operating current switch device located between a first electrode terminal and a positive terminal of a high voltage capacitor and a second high operating current switch device located between a second electrode terminal and a positive terminal of the high voltage capacitor. A second portion of the high voltage output circuit includes a third switch device located between the first electrode terminal and a negative terminal of the high voltage capacitor and a fourth switch device located between the second electrode terminal and the negative terminal of the high voltage capacitor. The bypass circuit is configured to couple a cardiac pacing voltage source to a cardiac pacing output path that excludes the first portion of the high voltage output circuit including the first switch device and the second switch device. Embodiment 4. A medical device according to any one of embodiments 2 to 3, wherein the bypass circuit includes at least one bypass switch device, and the control circuit is further configured to enable the bypass circuit by controlling at least one bypass switch device to conduct a cardiac pacing pulse signal to the cardiac pacing output path.
[0016] Embodiment 5. The medical device according to any one of embodiments 2 to 4, wherein the bypass circuit comprises a first channel and a second channel, the first channel comprises at least a first switch device, and the second channel comprises at least a second switch device. The control circuit is further configured to selectively enable the first switch device of the first channel or the second switch device of the second channel to conduct the cardiac pacing pulse signal to one of the first electrode terminal or the second electrode terminal, respectively, thereby bypassing the first part of the high voltage output circuit.
[0017] Embodiment 6. The medical device of any one of embodiments 1 to 5, wherein the high voltage charging circuit is further configured to generate the rail voltage by charging the high voltage capacitor to a voltage less than the shock voltage amplitude, and the cardiac pacing voltage source further comprises a voltage regulator configured to receive the rail voltage and generate the cardiac pacing pulse signal as a voltage regulated output signal. The bypass circuit is further configured to couple the voltage regulator to the cardiac pacing output path when enabled.
[0018] Embodiment 7. The medical device of any one of Embodiments 1 to 5, wherein the cardiac pacing voltage source further comprises at least one charge pump for generating a cardiac pacing pulse signal. The bypass circuit is configured to couple the cardiac pacing voltage source to the cardiac pacing output path by coupling the at least one charge pump to the cardiac pacing output path.
[0019] Embodiment 8. A medical device according to any one of embodiments 1 to 7, wherein the cardiac pacing voltage source further comprises: a first voltage source configured to generate a first cardiac pacing pulse having a first maximum voltage amplitude up to a first range of pacing pulse voltage amplitudes; and a second voltage source configured to generate a second cardiac pacing pulse signal having a second maximum voltage amplitude up to a second range of pacing pulse voltage amplitudes, the second maximum voltage amplitude being greater than the first maximum voltage amplitude. The bypass circuit is further configured to couple the cardiac pacing voltage source of the therapy delivery circuit to the cardiac pacing output path by selectively coupling one of the first voltage source or the second voltage source to the cardiac pacing output path.
[0020] Embodiment 9. The medical device of embodiment 8, wherein the first voltage source comprises: a low voltage capacitor chargeable to a first maximum voltage of a first range of pacing pulse voltage amplitudes; and a low voltage charging circuit configured to charge the low voltage capacitor to a first maximum voltage amplitude of the first range of pacing pulse voltage amplitudes. When the first voltage source is selected for delivering the first cardiac pacing pulse signal, the bypass circuit is further configured to selectively couple the first voltage source of the cardiac pacing voltage source to the cardiac pacing output by coupling the low voltage capacitor to the cardiac pacing output path.
[0021] Embodiment 10. The medical device of any one of embodiments 8 to 9, wherein the bypass circuit comprises a first channel and a second channel. The first channel may comprise a first switch device and a second switch device. The second switch may be coupled to the first electrode terminal.
[0022] The second channel may include a third switch device and a fourth switch device, and the fourth switch device may be coupled to the second electrode terminal. The medical device may further include a control circuit configured to: establish a cardiac pacing pulse voltage amplitude; compare the cardiac pacing pulse voltage amplitude with a first range of pacing pulse voltage amplitudes and a second range of pacing pulse voltage amplitudes; and select one of the first voltage source and the second voltage source based on the cardiac pacing pulse voltage amplitude falling within one of the corresponding first range of pacing pulse voltage amplitudes and the second range of pacing pulse voltage amplitudes. In response to selecting the first voltage source, the control circuit is configured to enable one of the second switch device of the first channel or the fourth switch device of the second channel to conduct the first cardiac pacing voltage signal to the corresponding one of the first terminal or the second terminal. In response to selecting the second voltage source, the control circuit is configured to enable one of the following: (a)
[0023] (a) a first switch device and a second switch device of the first channel, or (b) a third switch device and a fourth switch device of the second channel to conduct the second cardiac pacing voltage signal to a corresponding one of the first electrode terminal or the second electrode terminal.
[0024] Embodiment 11. The medical device of any one of Embodiments 8 to 10, wherein the second voltage source comprises a voltage regulator or one of a series of at least two charge pumps.
[0025] Embodiment 12. The medical device of any one of Embodiments 2 to 11, wherein the control circuit is further configured to detect a tachyarrhythmia based on at least one sensed cardiac signal. In response to the control circuit detecting the tachyarrhythmia, the high voltage therapy circuit is further configured to: charge the high voltage charging circuit to a shock voltage amplitude to generate a cardioversion / defibrillation shock pulse; and enable the first portion and the second portion of the high voltage output circuit to deliver the cardioversion / defibrillation shock pulse.
[0026] Embodiment 13. The medical device of any one of embodiments 1 to 12, wherein the first electrode terminal is coupleable to a first high surface area electrode and the second terminal is coupleable to a second high surface area electrode. The first high surface area electrode and the second high surface area electrode can be carried by an external cardiac lead.
[0027] Example 14. A method that can be performed by a medical device includes: generating a cardiac pacing pulse signal through a cardiac pacing voltage source of a therapy delivery circuit of the medical device, enabling a bypass circuit of the medical device to couple the cardiac pacing voltage source to a cardiac pacing output path. The cardiac pacing output path excludes a first portion of a high voltage output circuit of the therapy delivery circuit, the first portion being configured to couple a high voltage capacitor of the therapy delivery circuit to a first electrode terminal to deliver a cardioversion / defibrillation shock pulse. The cardiac pacing output path includes a second portion of the high voltage output circuit, the second portion being configured to couple the high voltage capacitor to a second electrode terminal to deliver a cardioversion / defibrillation shock pulse. The method further includes delivering the cardiac pacing pulse signal via the first electrode terminal and the second electrode terminal.
[0028] Embodiment 15. The method of embodiment 14, further comprising sensing at least one cardiac signal by the sensing circuit and determining, by the control circuit of the medical device, a need for cardiac pacing based on the at least one sensed cardiac signal. The method further comprises enabling, by the control circuit, a bypass circuit to couple a cardiac pacing voltage source of the therapy delivery circuit to a cardiac pacing output path in response to determining the need for cardiac pacing.
[0029] Embodiment 16. A method according to any one of Embodiments 14 to 15, the method further comprising: excluding the first portion by excluding a first high operating current switching device located between a positive terminal of a high voltage capacitor of a therapy delivery circuit and a first electrode terminal and a second high operating current switching device located between the positive terminal and the second electrode terminal of the high voltage capacitor from the cardiac pacing output path, enabling the bypass circuit to couple the cardiac pacing voltage source to the cardiac pacing output path. The high voltage capacitor is chargeable to a shock voltage amplitude. The method further comprises including the second portion by including in the cardiac pacing output path at least one of a third switching device located between the first electrode terminal and the negative terminal of the high voltage capacitor and a fourth switching device located between the second electrode terminal and the negative terminal of the high voltage capacitor.
[0030] Example 17. A method according to any one of Examples 14 to 16, wherein enabling the bypass circuit includes controlling at least one switching device of the bypass circuit to conduct the cardiac pacing pulse signal to the cardiac pacing output path.
[0031] Example 18. A method according to any one of Examples 14 to 17, wherein enabling the bypass circuit further includes selectively enabling at least one switching device of a first channel of the bypass circuit or a second channel of the bypass circuit through a control circuit of the medical device to conduct the cardiac pacing pulse signal to one of the first electrode terminal or the second electrode terminal via the at least one switching device, respectively, to bypass the first part of the high voltage output circuit.
[0032] Embodiment 19. The method of any one of Embodiments 14 to 18, further comprising: generating a cardiac pacing pulse signal by generating a rail voltage by charging a high voltage capacitor to a voltage less than a shock voltage amplitude; receiving the rail voltage via a voltage regulator; and generating the cardiac pacing pulse signal as a voltage regulated output signal of the voltage regulator. The method may further include enabling a bypass circuit of the medical device to couple a cardiac pacing voltage source to the cardiac pacing output path by enabling the bypass circuit to couple the voltage regulator to the cardiac pacing output path.
[0033] Example 20. A method according to any one of Examples 14 to 18, the method further comprising generating a cardiac pacing pulse signal through at least one charge pump of the therapy delivery circuit, and enabling the bypass circuit to couple a cardiac pacing voltage source to the cardiac pacing output path by coupling at least one charge pump to the cardiac pacing output path.
[0034] Embodiment 21. A method according to any one of Embodiments 14 to 20, wherein generating a cardiac pacing pulse signal comprises one of: generating the cardiac pacing pulse signal by a first voltage source of the cardiac pacing voltage source as a first cardiac pacing pulse signal having a first maximum voltage amplitude up to a first range of pacing pulse voltage amplitudes, or generating the cardiac pacing pulse signal by a second voltage source of the cardiac pacing voltage source as a second cardiac pacing pulse signal having a second maximum voltage amplitude up to a second range of pacing pulse voltage amplitudes. The second maximum voltage amplitude is greater than the first maximum voltage amplitude. The method further comprises enabling the bypass circuit to couple the cardiac pacing voltage source to the cardiac pacing output path by selectively coupling one of the first voltage source or the second voltage source to the cardiac pacing output path.
[0035] Embodiment 22. The method of embodiment 21, further comprising selecting one of a first voltage source or a second voltage source to generate a cardiac pacing pulse signal. When the first voltage source is selected, the method comprises: generating a first cardiac pacing pulse signal by the first voltage source by charging a low voltage capacitor of the therapy delivery circuit to a first maximum voltage amplitude of a first range of pacing pulse voltage amplitudes; and selectively coupling the first voltage source of the cardiac pacing voltage source to the cardiac pacing output by the bypass circuit by coupling the low voltage capacitor to the cardiac pacing output path.
[0036] Embodiment 23. A method according to any one of embodiments 21 to 22, wherein the bypass circuit includes a first channel, the first channel including a first switch device and a second switch device. The second switch device is coupled to the first electrode terminal. The bypass circuit further includes a second channel having a third switch device and a fourth switch device. The fourth switch device is coupled to the second electrode terminal. The method further includes: establishing a cardiac pacing pulse voltage amplitude; comparing the cardiac pacing pulse voltage amplitude with a first range of pacing pulse voltage amplitudes and a second range of pacing pulse voltage amplitudes; and selecting one of the first voltage source and the second voltage source based on the cardiac pacing pulse voltage amplitude falling into one of the corresponding first range of pacing pulse voltage amplitudes or the second range of pacing pulse voltage amplitudes. When the first voltage source is selected, one of the second switch device of the first channel or the fourth switch device of the second channel is enabled to conduct the first cardiac pacing voltage signal to the corresponding one of the first electrode terminal or the second electrode terminal. When the second voltage source is selected, one of the following is enabled: (a) the first switch device and the second switch device of the first channel, or (b) the third switch device and the fourth switch device of the second channel to conduct the second cardiac pacing voltage signal to a corresponding one of the first electrode terminal or the second electrode terminal.
[0037] Embodiment 24. The method of any one of Embodiments 21 to 23, wherein the second voltage source comprises a voltage regulator or one of a series of at least two charge pumps.
[0038] Embodiment 25. The method of any one of embodiments 15 to 24, further comprising: detecting a tachyarrhythmia based on at least one sensed cardiac signal;
[0039] Charging a high voltage capacitor of the therapy delivery circuit to a shock voltage amplitude to generate a cardioversion / defibrillation shock pulse; and enabling the first and second portions of the high voltage output circuit to deliver the cardioversion / defibrillation shock pulse.
[0040] Embodiment 26. The method of any one of Embodiments 14 to 25, wherein delivering a cardiac pacing pulse signal further comprises delivering a cardiac pacing pulse via a first electrode terminal coupled to a first high surface area electrode and a second terminal coupled to a second high surface area electrode. The first high surface area electrode and the second high surface area electrode may be carried by an external cardiac lead.
[0041] The present disclosure is intended to provide an overview of the subject matter described in the present disclosure. It is not intended to provide an exclusive or exhaustive explanation of the devices and methods described in detail in the following figures and descriptions. Further details of one or more examples are set forth in the following figures and descriptions. BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Figure 1A and Figure 1B is a conceptual diagram of an example of an ICD system that may be configured to sense cardiac event signals, detect arrhythmias, and deliver electrical stimulation therapy according to the techniques disclosed herein.
[0043] FIG. 2A to FIG. 2C Is implanted in Figure 1A to Figure 1B Conceptual diagrams of patients with ICD systems arranged in different implant configurations are shown.
[0044] Figure 3 is a conceptual diagram of an ICD according to an example.
[0045] Figure 4 Some examples may include Figure 3 Conceptual diagram of the circuit in the therapeutic delivery circuit.
[0046] Figure 5 According to some examples, it can be included in Figure 4 Diagram of a bypass circuit in a therapy delivery circuit.
[0047] Figure 6 is a conceptual diagram of a therapy delivery circuit according to another example.
[0048] Figure 7 is a conceptual diagram of a therapy delivery circuit according to another example.
[0049] Figure 8 is a flow chart of a method for delivering cardiac pacing pulses by an ICD according to some examples. DETAILED DESCRIPTION
[0050] In general, the present disclosure describes medical devices and techniques for delivering cardiac pacing pulses using relatively high surface area, low impedance electrodes that can be implanted at an extracardiac or extracardiovascular location. The high surface area electrodes can be used to deliver CV / DF shocks from the medical device by enabling a high voltage output circuit path for discharging a high voltage capacitor. A portion of the high voltage output circuit can be used to deliver cardiac pacing pulses via the high surface area electrodes using a bypass circuit that excludes a first portion of the high voltage output circuit and enables cardiac pacing pulses to be delivered via the high surface area electrode terminals and a second portion of the high voltage output circuit.
[0051] As used herein, the term "extracardiac" refers to a location outside the patient's heart, and may refer to a location outside the pericardium surrounding the heart. The extracardiac electrode may be carried by a non-transvenous lead or a transvenous lead. A transvenous extracardiac lead may carry implantable electrodes that may be positioned in an extracardiac location within a vein but outside the heart, for example, within an internal thoracic vein, a jugular vein, or another vein. As used herein, the term "extracardiac" refers to a location outside the patient's blood vessels and heart, which may also be located outside the pericardium surrounding the heart. Implantable electrodes carried by non-transvenous, extracardiac leads may be positioned outside the chest (outside the chest and sternum) or inside the chest (below the chest or sternum), but may not be in close contact with myocardial tissue.
[0052] As disclosed herein, a medical device includes a therapy delivery circuit including an operating circuit configured to deliver high voltage CV / DF shock pulses using a high surface area, low impedance electrode. The medical device is further configured to generate relatively low voltage cardiac pacing pulses that are delivered to the high surface area, low impedance electrode using a portion of the high voltage therapy delivery circuit that can also be used to deliver the CV / DF shock pulses. As described below, the therapy delivery circuit of the ICD may include a bypass circuit for bypassing a portion of the high voltage output circuit that requires a high operating current to control the delivery of the high voltage CV / DF shock.
[0053] When cardiac pacing pulse delivery is required, portions of the high voltage output circuit that require high operating current are disabled and bypassed to enable the therapy delivery circuit to deliver a relatively low voltage cardiac pacing pulse via the high surface area electrode. When a CV / DF shock is required, the bypass circuit is disabled and the high voltage output circuit is enabled so that a high voltage CV / DF shock can be delivered via the conductive state of components of the high voltage output circuit that may require high operating current. By bypassing one or more high operating current components of the high voltage output circuit during cardiac pacing pulse delivery, a cardiac pacing pulse having a relatively lower voltage amplitude than a CV / DF shock can be effectively delivered via the high surface area, low impedance electrode in a manner that uses less current from the ICD power supply and effectively captures the heart.
[0054] The technology disclosed herein can be implemented in any implantable or external or wearable pacemaker or ICD, particularly in a pacemaker or ICD having extracardiac electrodes. The electrodes can be carried by implantable medical electrical leads extending from the pacemaker or ICD and / or by the housing of the pacemaker or ICD. However, the technology disclosed herein is not necessarily limited to implantable systems and can be implemented in an external pacemaker or ICD using skin surface electrodes or transcutaneous electrodes.
[0055] Figure 1A and Figure 1B is a conceptual diagram of one example of an ICD system 10 that may be configured to sense cardiac electrical signals, detect tachyarrhythmias, and deliver electrical stimulation therapy according to the techniques disclosed herein. Figure 1A is a front view of ICD system 10 implanted in patient 12. Figure 1B is a side view of an ICD system 10 implanted in a patient 12. ICD system 10 includes an ICD 14 connected to electrical stimulation and sensing leads 16, which in this example are positioned at an extracardiovascular location. Figure 1A and Figure 1B Described in the context of an ICD system 10 that is capable of delivering high voltage CV / DF shocks and / or cardiac pacing pulses in response to detection of a cardiac arrhythmia based on processing of sensed cardiac electrical signals. The techniques disclosed herein for delivering cardiac electrical stimulation therapy can be implemented in a variety of medical devices including external, percutaneous, or implanted cardiac pacemakers and ICDs.
[0056] ICD 14 includes a housing 15 that forms an airtight seal that protects the internal components of ICD 14. The housing 15 of ICD 14 may be formed of a conductive material such as titanium or a titanium alloy. The housing 15 may act as an electrode (sometimes referred to as a "can" electrode). The housing 15 may be used as an active can electrode for delivering CV / DF shocks or other high voltage pulses delivered using a high voltage therapy circuit. In other examples, the housing 15 may be used to deliver unipolar, relatively low voltage cardiac pacing pulses and / or for sensing cardiac electrical signals in conjunction with electrodes carried by lead 16. In other cases, the housing 15 of ICD 14 may include a plurality of electrodes on an external portion of the housing. One or more external portions of the housing 15 that act as one or more electrodes may be coated with a material such as titanium nitride, for example, to reduce post-stimulation polarization artifacts.
[0057] ICD 14 includes a connector assembly 17 (also referred to as a connector block or header) that includes electrical feedthroughs that pass through housing 15 to provide electrical connections between conductors extending within lead bodies 18 of leads 16 and electronic components included within housing 15 of ICD 14. As will be described in further detail herein, housing 15 may house one or more processing circuits, memory, transceivers, cardiac electrical signal sensing circuitry, therapy delivery circuitry, power supplies, and other components for sensing cardiac electrical signals, detecting cardiac rhythms, and controlling and delivering electrical stimulation pulses to treat abnormal cardiac rhythms.
[0058] The elongated lead body 18 has a proximal end 27, which includes a lead connector (not shown) configured to connect to the ICD connector assembly 17, and a distal portion 25, which includes one or more electrodes. Figure 1A and Figure 1B In the example illustrated in , the distal portion 25 of the lead body 18 includes high surface area, low impedance electrodes 24 and 26 and relatively low surface area, high impedance electrodes 28 and 30. Electrodes 24 and 26 are elongated electrodes that can extend along a portion of the length of the lead body 18 to form relatively high surface area, low impedance electrodes that can be used to deliver high voltage CV / DF pulses. The CV shock pulse can be synchronized with the intrinsic R wave sensed by the ICD 14 to terminate non-sinus tachycardia. The DF shock pulse can be delivered to terminate fibrillation without synchronization with the sensed R wave. In either case, high voltage, high energy CV / DF shock pulses are delivered to the heart using high surface area electrodes (e.g., elongated coil electrodes) to simultaneously cause depolarization of a large portion of myocardial tissue. The simultaneous depolarization of a large portion of myocardial tissue is followed by repolarization of the large portion and an associated physiological refractory state, which disrupts the conduction of abnormal depolarizations through the heart that cause tachyarrhythmias. In this manner, the tachyarrhythmia can be successfully terminated because the heart's normal, intrinsic electrical conduction system (or cardiac pacing pulse) can initiate the next heartbeat to restore a more normal, organized propagation and conduction of myocardial depolarization through the heart.
[0059] High surface area electrodes (such as electrodes 24 and 26 and / or housing 24) are used to deliver CV / DF shocks so as to enclose a large portion of the heart within the electric field between the electrodes selected in the CV / DF electrode vector and to avoid tissue damage at the electrode site that may occur when high voltage shocks are delivered via lower electrode surface areas, thereby resulting in high current density at a more localized tissue site. Electrodes 24 and 26 can be configured to be activated simultaneously to form a large surface area, low impedance anode or cathode. Alternatively, electrodes 24 and 26 can form separate high surface area, low impedance electrodes, in which case each of electrodes 24 and 26 can be independently activated, for example as an anode or cathode, for delivering CV / DF shock pulses.
[0060] As disclosed herein, electrodes 24 and 26 can be selected for delivering cardiac pacing pulses having voltage amplitudes much lower than CV / DF shocks, but can be higher voltage than the voltage amplitudes required for cardiac pacing pulses delivered using endocardial or epicardial pacing electrodes. One electrode 24 or 26 can be used as a pacing cathode, while the other electrode 26 or 24 is used as a return anode. In other examples, one electrode 24 or 26, or both selected electrodes 24 and 26, can be used as a pacing cathode, and housing 15 or another available electrode is used as a return anode electrode.
[0061] For convenience, electrodes 24 and 26 are referred to herein as "coil electrodes" because they can take the form of a coiled electrode (a coiled electrode can include a single wire or filament or multiple wires or filaments, such as a braided multi-filament wire, a twisted multi-filament wire, etc.) that is wrapped around a longitudinal portion of lead body 18 to provide a relatively high surface area for delivering high voltage CV / DF shocks. However, it should be understood that electrodes 24 and 26 can be configured as other types of high surface area electrodes that can be used to deliver CV / DF shocks, which can include ribbon electrodes, plate electrodes, serpentine electrodes, zigzag electrodes, or other types of physical electrode configurations that provide relatively large surface areas and low impedance and do not necessarily include coiled wires.
[0062] Coil electrodes 24 and 26 (and in some examples, housing 15) are sometimes referred to as defibrillation electrodes or "CV / DF electrodes" because they are used, either individually or collectively, to deliver high voltage CV / DF shocks. However, as disclosed herein, coil electrodes 24 and 26 (and housing 15 in some examples) can be used in a cardiac pacing electrode vector to provide cardiac pacing pulse delivery. In addition, in some examples, coil electrodes 24 and 26 can be used in a sensing electrode vector to provide sensing functionality, in addition to being used to deliver high voltage CV / DF shocks and / or cardiac pacing pulses. In this sense, the use of the terms "defibrillation electrodes" or "CV / DF electrodes" herein should not be considered to limit the use of electrodes 24 and 26 only in high voltage CV / DF shock therapy applications. For example, any one of coil electrodes 24 and 26 can be used as a sensing electrode in a sensing electrode vector for sensing cardiac electrical signals and determining the need for electrical stimulation therapy. In addition, any one of coil electrodes 24 and 26 or both coil electrodes can be used in a cardiac pacing electrode vector to deliver cardiac pacing pulses according to the techniques disclosed herein. Although two coil electrodes 24 and 26 are shown along lead body 18, in other examples, lead body 18 may carry only one coil electrode (which may be used in combination with housing 15 to deliver high voltage pulses) or three or more coil electrodes. In still other examples, the two or more coil electrodes may be carried by two or more different lead bodies extending from ICD 14.
[0063] Electrodes 28 and 30 are electrodes with relatively small surface areas that can be used by sensing electrode vectors to sense cardiac electrical signals, and in some examples can be used to deliver relatively low voltage pacing pulses. Electrodes 28 and 30 are sometimes referred to as "pacing electrodes / sensing electrodes" because they are typically configured for use in relatively low voltage applications, for example, as cathodes or anodes for delivering pacing pulses and / or sensing cardiac electrical signals, as opposed to delivering high voltage CV / DF shocks. In some cases, electrodes 28 and 30 may provide only pacing functionality, only sensing functionality, or both.
[0064] Electrodes 28 and 30 may be ring electrodes that extend around the periphery of lead body 18 and have a relatively short longitudinal dimension along the length of lead body 18 compared to coil electrodes 24 and 26. For convenience, electrodes 28 and 30 are referred to herein as "ring electrodes" to distinguish them from relatively large surface area, low impedance electrodes 24 and 26 (referred to herein as "coil electrodes"). However, electrodes 28 and 30 may include any of a variety of different types of electrodes, including ring electrodes, short coil electrodes, button electrodes, hemispherical electrodes, directional electrodes, segmented electrodes, spiral electrodes, fishhook electrodes, tip electrodes, etc., and are not limited to only ring electrodes.
[0065] exist Figure 1A and Figure 1B In the example illustrated in , ring electrode 28 is located proximal to coil electrode 24, and ring electrode 30 is located between coil electrodes 24 and 26. Ring electrodes 28 and 30 may be positioned at other locations along lead body 18 and are not limited to the locations shown. One, two or more ring electrodes or other low surface area electrodes for sensing and / or low voltage cardiac pacing pulse delivery may be carried by lead body 18. For example, in some examples, a third ring electrode may be located distal to coil electrode 26. In other examples, lead 16 may include fewer or more ring electrodes and / or coil electrodes than the examples shown here.
[0066] In some cases, a post-shock cardiac pacing pulse is required to prevent cardiac arrest after a CV / DF shock until the intrinsic conduction system initiates an intrinsic cardiac rhythm. In other cases, for example, cardiac pacing may be required to treat bradycardia, cardiac arrest, or to deliver anti-tachycardia pacing (ATP). Cardiac pacing pulses are typically much lower in voltage than CV / DF shock pulses because a much smaller relative local volume of cardiac tissue can be captured by the pacing pulse to cause a heartbeat compared to a relatively large portion of cardiac tissue that is simultaneously depolarized during a CV / DF shock. Cardiac pacing pulses are delivered to cause depolarization of myocardial tissue at one or more local pacing sites. The pacing-induced depolarization of local cardiac cells captured near the pacing cathode electrode is conducted through the heart in a coordinated manner via the myocardium and / or the intrinsic conduction system to cause a paced heartbeat.
[0067] In some pacemaker and ICD systems, cardiac pacing pulses may be delivered using relatively low surface area electrodes carried by endocardial or epicardial leads, similar to ring electrodes 28 and 30, such that the low surface area electrodes are in close or intimate contact with the myocardial tissue. For example, pacing pulses delivered using low surface area, transvenous, endocardial electrodes may typically have a voltage amplitude of up to a maximum of 8 volts (V) and a pulse width of 2.0 ms or less. More typically, for example, a pacing pulse that successfully paces the heart via an endocardial or epicardial electrode may be a pulse amplitude of 1.0 V to 5.0 V, such as 2.5 V, and a pulse width of 0.25 ms to 0.5 ms. The pulse amplitude and pulse width of the pacing pulse are selected to deliver sufficient energy to cause electrical depolarization of the myocardial tissue of the heart at the pacing site, thereby capturing the heart and inducing a heartbeat.
[0068] Cardiac pacing pulses delivered using extracardiac electrodes typically require higher energy (e.g., higher pulse amplitude and / or pulse width) than cardiac pacing pulses delivered using endocardial or epicardial electrodes, but the pacing voltage amplitude and pulse energy are still lower than the pacing voltage amplitude and pulse energy required for CV / DF shocks. When pacing using extracardiac electrodes, relatively high voltage cardiac pacing pulses are required to deliver sufficient energy to capture the heart within the pacing pulse width. The limitation of the maximum pacing pulse width may be due in part to the decay rate of the pacing pulse amplitude, which may depend on the capacitance of the capacitor discharged to deliver the pacing pulse and the impedance of the pacing electrode vector. Therefore, in order to achieve capture within a limited pulse width (e.g., 2ms or less), a high pacing voltage amplitude may be required to deliver sufficient pacing pulse energy. For example, cardiac pacing pulses delivered using extracardiac electrodes can be in the range of 8V to 40V, with a pacing pulse width of 2ms to 8ms. By comparison, CV / DF shocks can be greater than 100V or approximately several hundred volts.
[0069] As described below, high surface area coil electrodes 24 and 26 can be used to deliver cardiac pacing pulses. The lower current density at the electrode tissue interface of the high surface area coil electrodes 24 and 26 can use relatively higher pacing pulse voltage amplitudes compared to the low surface area electrodes 28 and 30. The surface area of the coil electrode 24 or 26 can be 50 to 100 times the surface area of the ring electrodes 28 and 30. During relatively high voltage cardiac pacing, the high current density at the ring electrode-tissue interface may cause local tissue damage. The electric field of the current traveling through the conductive tissue toward the heart between the cardiac pacing electrode vectors including at least one or two high surface area coil electrodes 24 and 26 may be more effective in capturing the heart for cardiac pacing than the electric field between the cardiac pacing electrode vectors including the lower surface area ring electrodes 28 and 30 or one of the ring electrodes 28 or 30 and the housing 15. The higher voltage cardiac pacing pulses that can be delivered via the coil electrodes 24 and 26 can have relatively short pulse widths so that the pacing pulse decay rate will not become a limiting factor in delivering the pacing pulse energy for capturing the heart.
[0070] Thus, as described below, the ICD 14 can be configured to deliver cardiac pacing pulses using the coil electrodes 24 and 26 (e.g., as a cathode and anode pair). When a CV / DF shock is required to be delivered via the coil electrodes 24 and / or 26, the high voltage output circuit of the ICD 14 is enabled by the therapy delivery control circuit of the ICD 14. However, when a relatively high voltage cardiac pacing pulse is required that is much lower in voltage than the CV / DF shock pulse, the ICD 14 is configured to enable a bypass circuit to deliver the cardiac pacing pulse to one or both of the coil electrodes 24 and 26 using only a portion of the high voltage output circuit. The current required to operate the high voltage output circuit is reduced by enabling the bypass circuit for delivering the cardiac pacing pulse to the coil electrodes 24 and / or 26 via only a portion of the high voltage output circuit, compared to the current required to operate the high voltage output circuit to deliver the CV / DF shock.
[0071] Reference again Figure 1A and Figure 1B In the example shown in FIG. 1 , lead 16 extends from connector assembly 27 of ICD 14 toward the center of patient 12's torso (e.g., toward xiphoid process 20 of patient 12) in the middle of thorax 32, subcutaneously or submuscularly. At a location near xiphoid process 20, lead 16 bends or turns and extends upward, subcutaneously or submuscularly, above the thorax and / or sternum, substantially parallel to sternum 22. Although in FIG. Figure 1A2 is shown as being laterally offset from and extending substantially parallel to the sternum 22, but the distal portion 25 of the lead 16 may be implanted in other locations, such as above the sternum 22, offset to the right or left side of the sternum 22, or laterally angled to the left or right side from the sternum 22, etc. Alternatively, the lead 16 may be placed along other subcutaneous or submuscular paths. The path of the cardiovascular external lead 16 may depend on the location of the ICD 14, the arrangement and location of the electrodes carried by the lead body 18, and / or other factors. The technology disclosed herein is not limited to a specific path of the lead 16 or the final location of the electrodes 24, 26, 28, and 30.
[0072] Electrical conductors (not shown) extend from a lead connector at a proximal lead end 27 through one or more lumens of the elongated lead body 18 of the lead 16 to electrodes 24, 26, 28, and 30 located along a distal portion 25 of the lead body 18. The elongated electrical conductors contained within the lead body 18 (which may be separate respective insulated conductors within the lead body 18) are each electrically coupled to respective coil electrodes 24 and 26 and ring electrodes 28 and 30. The respective conductors electrically couple the electrodes 24, 26, 28, and 30 to circuitry (such as therapy delivery circuitry and / or sensing circuitry) of the ICD 14 via connections in the connector assembly 17 (including associated electrical feedthroughs that pass through the housing 15). The electrical conductors transmit electrical stimulation pulses from the therapy delivery circuitry within the ICD 14 to one or more of the coil electrodes 24 and 26 and / or the ring electrodes 28 and 30, and transmit electrical signals generated by the patient's heart 8 from the coil electrodes 24 and 26 and / or the ring electrodes 28 and 30 to the sensing circuitry within the ICD 14.
[0073] The lead body 18 of the lead 16 can be formed of a non-conductive material (including silicone, polyurethane, fluoropolymer, mixtures thereof, and / or other suitable materials) and is shaped to form one or more lumens in which one or more conductors extend. The lead body 18 can be tubular or cylindrical in shape. In other examples, the distal portion 25 (or all) of the elongated lead body 18 can have a flat, ribbon-like or paddle-like shape. The lead body 18 can be formed to have a preformed distal portion 25 that is typically straight, curved, bent, serpentine, wavy or zigzag.
[0074] In the example shown, lead body 18 includes a curved distal portion 25 having two "C"-shaped curves, which together may resemble the Greek letter epsilon "ε". Defibrillation electrodes 24 and 26 are each carried in part by one of the two corresponding C-shaped portions of lead body distal portion 25. The two C-shaped curves extend or curve in the same direction away from the central axis of lead body 18, along which ring electrodes 28 and 30 are positioned. In some cases, ring electrodes 28 and 30 may be substantially aligned with the central axis of the straight proximal portion of lead body 18, such that the midpoints of coil electrodes 24 and 26 are laterally offset from ring electrodes 28 and 30.
[0075] Other examples of cardiovascular external leads that can be implemented with the technology described herein, including one or more coil electrodes and one or more ring electrodes carried by a curved, serpentine, wavy, or zigzag distal portion of the lead body 18, are generally disclosed in U.S. Pat. No. 10,675,478 (Marshall et al.). However, the technology disclosed herein is not limited to any particular lead body design. In other examples, the lead body 18 is a flexible, elongated lead body that does not have any preformed shape, bends, or bends.
[0076] The ICD 14 may obtain cardiac electrical signals corresponding to the electrical activity of the heart 8 via a combination of sensing electrode vectors including a combination of electrodes 24, 26, 28 and / or 30. In some examples, the housing 15 of the ICD 14 is used in combination with one or more of the electrodes 24, 26, 28 and / or 30 in at least one sensing electrode vector. Each cardiac electrical signal received via the selected sensing electrode vector may be used by the ICD 14 to sense cardiac event signals associated with intrinsic depolarizations of the myocardium, such as R waves associated with ventricular depolarization and P waves associated with atrial depolarization in some cases. The sensed cardiac event signals may be used to determine the heart rate and determine the need for cardiac pacing, such as to treat bradycardia or asystole to prevent long ventricular pauses, or to determine the need for tachyarrhythmia treatment, such as ATP and / or CV / DF shocks.
[0077] The ICD 14 analyzes cardiac electrical signals received from one or more sensing electrode vectors to monitor abnormal rhythms, such as cardiac arrest, bradycardia, ventricular tachycardia (VT), or ventricular fibrillation (VF). The ICD 14 may analyze the heart rate and / or the morphology of the cardiac electrical signals to monitor tachyarrhythmias according to any tachyarrhythmia detection technique. The ICD 14 generates and delivers electrical stimulation therapy in response to detecting a tachyarrhythmia (e.g., VT or VF (VT / VF)) using a therapy delivery electrode vector that may be selected from any of the available electrodes 24, 26, 28, 30 and / or the housing 15. The ICD 14 may deliver ATP in response to VT detection, and in some cases may deliver ATP before a CV / DF shock or during charging of a high voltage holding capacitor in an attempt to avoid the need to deliver a CV / DF shock. If ATP does not successfully terminate VT or when VF is detected, ICD 14 may deliver one or more CV / DF shocks via one or both of coil electrodes 24 and 26 and / or housing 15 .
[0078] In the absence of a ventricular event signal (e.g., a sensed R wave), ICD 14 may generate and deliver a cardiac pacing pulse, such as a post-shock pacing pulse or a bradycardia pacing pulse when asystole is detected or when a pacing escape interval expires before a ventricular event signal is sensed (e.g., when AV block is present). In accordance with the techniques disclosed herein, a pacing electrode vector including at least one coil electrode or both coil electrodes of coil electrodes 24 and 26 may be used to deliver cardiac pacing pulses.
[0079] ICD 14 is shown as being implanted subcutaneously on the left side of patient 12 along thorax 32. In some cases, ICD 14 may be implanted between the left posterior axillary line and the left anterior axillary line of patient 12. However, ICD 14 may be implanted at other subcutaneous or submuscular locations in patient 12. For example, ICD 14 may be implanted in a subcutaneous pocket in the pectoralis region. In this case, lead 16 may extend from ICD 14 subcutaneously or submuscularly toward the shank of sternum 22, and bend or turn downward from the shank and extend to a desired location subcutaneously or submuscularly. In yet another example, ICD 14 may be placed in the abdomen. Lead 16 may also be implanted in other extracardiac locations. For example, as described with respect to FIG. 2A to FIG. 2C As described, the distal portion 25 of the lead 16 may be implanted beneath the sternum / thoracic cavity in the substernal space. Figure 1A and Figure 1B It is illustrative in nature and should not be construed as limiting the practice of the technology disclosed herein.
[0080] In various examples, a medical device operating according to the techniques disclosed herein may be coupled to a transvenous or non-transvenous lead for carrying electrodes for sensing cardiac electrical signals and delivering electrical stimulation therapy. For example, a medical device such as an ICD 14 may be coupled to a cardiovascular external lead as shown in the accompanying drawings, which refers to a lead that positions electrodes outside of the patient's blood vessels, heart, and pericardium surrounding the heart. The implantable electrodes carried by the cardiovascular external lead may be positioned outside the thorax (outside the chest and sternum), subcutaneously, or under the muscle, or inside the thorax (below the chest or sternum, sometimes referred to as a sub-sternal position), and may not necessarily be in close contact with the myocardial tissue. Cardiovascular external leads may also be referred to as "non-transvenous" leads.
[0081] In other examples, the medical device may be coupled to a transvenous lead that positions the electrode within a blood vessel, which may remain in an extracardiac location outside the heart or be advanced to position the electrode within a heart chamber. For example, as an example, a transvenous medical lead may be advanced along a venous pathway to position the electrode within an extracardiac location within an internal thoracic vein (ITV), an intercostal vein, an epigastric vein, or an azygos, hemiazygos, or para-hemiazygos vein. In yet other examples, the transvenous lead may be advanced to position the electrode within the heart, for example, within a heart chamber of the atria and / or ventricles.
[0082] exist Figure 1A , external device 40 is shown in telemetric communication with ICD 14 via wireless communication link 42. External device 40 may include processor 52, memory 53, display 54, user interface 56, and telemetry unit 58. Processor 52 controls external device operation and processes data and signals received from ICD 14. Display unit 54, which may include a graphical user interface, displays data and other information to a user to view ICD operating and programming parameters and cardiac electrical signals retrieved from ICD 14.
[0083] User interface 56 may include a mouse, touch screen, keypad, etc. to enable a user to interact with external device 40 to initiate a telemetry session with ICD 14 to retrieve data from and / or transmit data to ICD 14, including programmable parameters for controlling cardiac event signal sensing, arrhythmia detection, and therapy delivery. Telemetry unit 58 includes a transceiver and antenna configured for bidirectional communication with telemetry circuitry included in ICD 14 and configured to operate in conjunction with processor 52 to send and receive data related to ICD functions via communication link 42.
[0084] You can use A radio frequency (RF) link, such as Wi-Fi or Medical Implant Communications Service (MICS) or other RF or communications frequency bandwidth or communications protocol, establishes a communications link 42 between the ICD 14 and the external device 40. Data stored or acquired by the ICD 14, including physiological signals or associated data derived therefrom, results of device diagnostics, battery status, and a history of detected rhythm episodes and delivered therapies, etc., can be retrieved from the ICD 14 by the external device 40 following an interrogation command.
[0085] The external device 40 may be embodied as a programmer used in a hospital, clinic, or physician's office to retrieve data from the ICD 14 and program operating parameters and algorithms in the ICD 14 to control ICD functions. The external device 40 may alternatively be embodied as a home monitor or handheld device. The external device 40 may be used to program cardiac signal sensing parameters, cardiac rhythm detection parameters, and therapy control parameters used by the ICD 14. In some examples, at least some of the control parameters used in sensing cardiac event signals and detecting tachyarrhythmias, as well as therapy delivery control parameters, may be programmed into the ICD 14 using the external device 40. For example, a user may program a pacing voltage amplitude and a pacing electrode vector including at least one or both coil electrodes 24 and 26. As described below, the processing and control circuitry enclosed by the housing 15 may select a cardiac pacing pulse voltage source and a therapy delivery output circuit based on the programmed pacing pulse voltage amplitude to deliver cardiac pacing pulses via at least one coil electrode 24 or 26.
[0086] FIG. 2A to FIG. 2C Patient 12 is different from Figure 1A to Figure 1B The illustrated arrangement is a conceptual diagram of an extracardiovascular ICD system 10 implanted in an implant configuration. Figure 2A is a front view of patient 12 having ICD system 10 implanted therein. Figure 2B is a side view of patient 12 having ICD system 10 implanted therein. Figure 2C 1 is a lateral view of a patient 12 implanted with an ICD system 10. In this arrangement, the cardiovascular external lead 16 of the system 10 is at least partially implanted beneath the sternum 22 of the patient 12. The lead 16 extends subcutaneously or submuscularly from the ICD 14 toward the xiphoid process 20 and bends or turns within the anterior mediastinum 36 in a substernal position at a location near the xiphoid process 20 and extends upward (see FIG. Figure 2C ).
[0087] The anterior mediastinum 36 can be viewed as being bounded laterally by the pleura 39, posteriorly by the pericardium 38, and anteriorly by the sternum 22 (see Figure 2C). The distal portion 25 of the lead 16 may extend substantially along the posterior side of the sternum 22 within the loose connective tissue and / or substernal musculature of the anterior mediastinum 36. A lead implanted so that the distal portion 25 is substantially within the anterior mediastinum 36 may be referred to as a "substernal lead."
[0088] exist FIG. 2A to FIG. 2C In the example shown, lead 16 is positioned substantially centered beneath sternum 22. However, in other cases, lead 16 is implanted such that it is laterally offset from the center of sternum 22. In some cases, lead 16 may extend laterally such that distal portion 25 of lead 16 is below / under thoracic cavity 32 in addition to or in lieu of sternum 22. In other examples, distal portion 25 of lead 16 may be implanted in other extracardiac intrathoracic locations, including in the pleural cavity or around the periphery of pericardium 38 of heart 8 and adjacent to the pericardium of the heart.
[0089] Figure 3 1 is a conceptual diagram of an ICD 14 according to an example. The electronic circuitry enclosed in the housing 15 (in Figure 3 The ICD 14 may be coupled to leads, such as a Figures 1A to 2C Leads 16 carrying electrodes 24, 26, 28 and 30 are shown in the example of FIG. 1 for delivering electrical stimulation pulses to the patient's heart and for sensing cardiac electrical signals.
[0090] ICD 14 includes control circuitry 80, memory 82, therapy delivery circuitry 84, cardiac electrical signal sensing circuitry 86, and telemetry circuitry 88. Power supply 98 supplies power to the circuitry of ICD 14, including each of components 80, 82, 84, 86, and 88 as required. Power supply 98 may include one or more energy storage devices, such as one or more rechargeable or non-rechargeable batteries. Connections between power supply 98 and each of components 80, 82, 84, 86, and 88 will be from Figure 3 84, but are not shown for clarity. For example, the power supply 98 may be coupled to one or more charging circuits included in the therapy delivery circuit 84 for charging the holding capacitors included in the therapy delivery circuit 84, and operating the output circuits to discharge the holding capacitors at appropriate times under the control of the control circuit 80 to generate electrical pulses according to the therapy protocol. The power supply 98 is also coupled to components of the cardiac electrical signal sensing circuit 86 (such as sense amplifiers, analog-to-digital converters, switching circuits, etc.), the memory 82, and the telemetry circuit 88 as needed.
[0091] Figure 3The operational circuits shown are representative of functionality included in the ICD 14 and may include any discrete and / or integrated electronic circuit components that implement analog circuits and / or digital circuits capable of producing the functions attributed to the ICD 14 herein. The functionality associated with one or more circuits may be performed by separate hardware components, firmware components, and / or software components, or integrated within common hardware components, firmware components, and / or software components. For example, cardiac electrical signal sensing and analysis for detecting arrhythmias may be performed cooperatively by the sensing circuit 86 and the control circuit 80, and may include operations implemented in other signal processing circuits included in the processor or control circuit 80, which executes instructions and control signals stored in the memory 82, such as blanking intervals and timing periods and sensing threshold amplitude signals sent from the control circuit 80 to the sensing circuit 86. Therapy delivery can be performed cooperatively by therapy delivery circuitry 84 under the control of signals received from control circuitry 80, which are used to control the timing, amplitude, width, polarity, rate, electrode vector, and other therapy delivery parameters used by the therapy delivery circuitry to generate and deliver electrical stimulation pulses, which may include CV / DF pulses, cardiac pacing pulses, tachyarrhythmia inducing pulses, impedance measurement pulses, or any other electrical pulses delivered via electrodes 24, 26, 28, 30 and / or housing 15.
[0092] The various circuits of the ICD 14 may include application specific integrated circuits (ASICs), electronic circuits, (shared, dedicated, or group) processors and memories that execute one or more software or firmware programs, combinational logic circuits, state machines, hardware subroutines, or other suitable components or combinations of components that provide the described functionality. The specific form of software, hardware, and / or firmware used to implement the functionality disclosed herein will be determined primarily by the specific system architecture employed in the ICD and the specific sensing, detection, and therapy delivery methods employed by the ICD. Given the disclosure herein, it is within the capabilities of those skilled in the art to provide software, hardware, and / or firmware to implement the described functionality in the context of any modern medical device system.
[0093] Memory 82 may include any volatile, nonvolatile, magnetic, or electrically non-transitory computer-readable storage medium, such as random access memory (RAM), read-only memory (ROM), nonvolatile RAM (NVRAM), electrically erasable programmable ROM (EEPROM), flash memory, or any other memory device. In addition, memory 82 may include a non-transitory computer-readable medium storing instructions that, when executed by one or more processing circuits, cause control circuit 80 and / or other ICD components to perform various functions pertaining to ICD 14 or those ICD components. The non-transitory computer-readable medium storing instructions may include any of the media listed above.
[0094] The therapy delivery circuit 84 and the sensing circuit 86 are electrically coupled to the electrodes 24, 26, 28, 30 carried by the lead 16 and the housing 15, which may act as a common or ground electrode for sensing or cardiac pacing pulses or as an active can electrode for delivering CV / DF shock pulses. The control circuit 80 communicates with the therapy delivery circuit 84 and the sensing circuit 86, for example via a data bus, for sensing cardiac electrical signals, detecting cardiac rhythms, and controlling the delivery of cardiac electrical stimulation therapy in response to the sensed cardiac signals (or the absence of the cardiac signals). The control circuit 80 may include an arrhythmia detection circuit 92, a timing circuit 90, and a therapy control circuit 94. The arrhythmia detection circuit 92 may be configured to process and analyze signals received from the sensing circuit 86, which may be combined with time intervals and / or timing-related signals received from the timing circuit 90. The timing circuit 90 may generate a clock signal and include various timers and / or counters to determine time intervals between sensed and / or paced cardiac events, and control the timing of delivered pacing pulses and / or CV shocks. The control circuit 80 further may include a therapy control circuit 94 configured to transmit signals to and receive signals from the therapy delivery circuit 84 to control and monitor the electrical stimulation therapy delivered by the therapy delivery circuit 84 .
[0095] The cardiac electrical signal sensing circuit 86 (also referred to herein as "sensing circuit" 86) may be selectively coupled to the electrodes 28, 30 and / or the housing 15 to monitor the electrical activity of the patient's heart. The sensing circuit 86 may additionally be selectively coupled to the defibrillation electrodes 24 and / or 26 for use in a sensing electrode vector together or in combination with one or more of the electrodes 28, 30 and / or the housing 15. In some examples, the sensing circuit 86 may be enabled to receive cardiac electrical signals from at least one sensing electrode vector selected from the available electrodes 24, 26, 28, 30 and the housing 15. In some examples, at least two, three or more cardiac electrical signals from two, three or more different sensing electrode vectors may be received simultaneously by the sensing circuit 86. The sensing circuit 86 may monitor one or more cardiac electrical signals to sense cardiac event signals, such as an R wave accompanying intrinsic ventricular myocardial depolarization. In some examples, the sensing circuit 86 may be configured to monitor two cardiac electrical signals simultaneously to sense cardiac event signals. At least one cardiac electrical signal may be received by sensing circuit 86 and transmitted to control circuit 80 (e.g., by arrhythmia detection circuit 92) for processing and analysis to determine when morphology-based criteria for detecting an arrhythmia are met in some examples.
[0096] In the example shown, the sensing circuit 86 may include a switching circuit for selecting which of the electrodes 24, 26, 28, 30 and the housing 15 are coupled as first sensing electrode vectors to a first sensing channel 83 for receiving a first cardiac electrical signal, which electrodes are coupled as second sensing electrode vectors to a second sensing channel 85 of the sensing circuit 86 for receiving a second cardiac electrical signal, and which electrodes are coupled as third sensing electrode vectors to a morphological signal channel 87 for receiving a third cardiac electrical signal.
[0097] When included, each sensing channel 83 and 85 can be configured to amplify, filter, and digitize cardiac electrical signals received from selected electrodes coupled to the corresponding sensing channel to improve signal quality for sensing cardiac event signals such as R waves. The cardiac event detection circuit within the sensing circuit 86 may include one or more sensing amplifiers, filters, rectifiers, threshold detectors, comparators, analog-to-digital converters (ADCs), timers, or other analog and / or digital components. The cardiac event sensing threshold can be automatically adjusted by each sensing channel 83 and 85 under the control of the control circuit 80 based on sensing threshold control parameters (such as various timing periods) and sensing threshold amplitude values determined by the control circuit 80, stored in the memory 82, and / or controlled by the hardware, firmware, and / or software of the control circuit 80 and / or the sensing circuit 86. In response to sensing a cardiac event signal (e.g., an R wave), the sensing circuit 86 can generate a sensed event signal (e.g., a ventricular sensed event signal) that is transmitted to the control circuit 80.
[0098] The ventricular sensed event signals received by the control circuit 80 from the sensing circuit 86 may be used by the control circuit 80 to determine a sensed event interval, which may be referred to herein as an RR interval (or RRI). The RRI is a time interval between two ventricular sensed event signals received by the control circuit 80. The control circuit 80 may include a timing circuit 90 for determining the RRI. In some examples, the control circuit 80 may detect VT / VF based on the RRI. The RRI may include a time interval between consecutive ventricular sensed event signals and an interval between a delivered pacing pulse and a ventricular sensed event signal.
[0099] In some examples, the sensing circuit 86 receives a third cardiac electrical signal through a morphology signal channel 87 for transmitting a digitized electrocardiogram (ECG) signal to the control circuit 80 for morphology analysis. The three cardiac electrical signals sensed by the sensing circuit 86 can be received using three different sensing electrode vectors selected from the available electrodes 24, 26, 28 and 30 and the housing 15. In other examples, the sensing circuit 86 can receive two cardiac electrical signals from two different sensing electrode vectors, one of which is transmitted to the first sensing channel 83 and the other is transmitted to the second sensing channel 85. Either or both of the two signals can be transmitted to the control circuit 80 as a multi-bit digital ECG signal, which is used by the control circuit 80 for morphology analysis of the cardiac signal. However, in some examples, multiple channels 83, 85 and 87 can be optional. Aspects of the technology for delivering therapeutic electrical stimulation pulses disclosed herein can be implemented in combination with a variety of cardiac event signal sensing and arrhythmia detection methods, and are not limited to any particular method for determining the need or timing of electrical pulses delivered by the therapy delivery circuit 84.
[0100] Timing circuit 90 may be configured to control various timers and / or counters used to set various intervals and windows for sensing ventricular event signals, determine time intervals between received ventricular sensed event signals, perform morphology analysis, and control the timing of cardiac pacing pulses generated by therapy delivery circuit 84. Timing circuit 90 may initiate a timer in response to receiving a ventricular sensed event signal from sensing channels 83 and 85 and used to time the RRI. Timing circuit 90 may communicate the RRI to arrhythmia detection circuit 92 to determine and count tachyarrhythmia intervals.
[0101] The control circuit 80 may include an arrhythmia detection circuit 92 configured to analyze the RRI received from the timing circuit 90 and the cardiac electrical signal received from the morphology signal channel 87 to detect arrhythmias. The arrhythmia detection circuit 92 may be configured to detect cardiac arrest and / or tachyarrhythmia based on the sensed cardiac electrical signal satisfying the corresponding asystole or tachyarrhythmia detection criteria. The arrhythmia detection circuit 92 may be implemented in the control circuit 80 as hardware, software and / or firmware that processes and analyzes the signal received from the sensing circuit 86 to detect VT / VF. In some examples, the arrhythmia detection circuit 92 may include a comparator and a counter for counting the RRI determined by the timing circuit 90 as a tachyarrhythmia interval. An RRI that is less than the tachyarrhythmia detection interval is referred to as a "tachyarrhythmia interval." The arrhythmia detection circuit 92 may compare the RRI determined by the timing circuit 90 with one or more tachyarrhythmia detection interval zones, such as a VT detection interval zone and a VF detection interval zone. The RRI that falls into the detection interval zone is counted by the corresponding VT interval counter or VF interval counter, and in some cases, in the combined VT / VF interval counter. When a threshold number of tachyarrhythmia intervals is reached, the control circuit 80 may detect VT or VF. In some examples, a tachyarrhythmia detection based on reaching a threshold number of tachyarrhythmia intervals may be confirmed or rejected based on a morphological analysis of the cardiac electrical signal.
[0102] As an example, the VF detection interval threshold may be set to 280 milliseconds (ms) to 350 milliseconds. When VT detection is enabled, the VT detection interval may be programmed to be in the range of 350 ms to 42 ms, or 400 ms for example. VT or VF may be detected when the corresponding VT or VF interval counter (or combined VT / VF interval counter) reaches a threshold number of detection intervals (NID). For example, the NID for detecting VT may require the VT interval counter to reach 18 VT intervals, 24 VT intervals, 32 VT intervals, or other selected number of VT intervals. The VT intervals may need to be consecutive intervals, or may not need to be consecutive intervals. The NID required to detect VF may be programmed to a threshold number of X VF intervals in Y consecutive RRIs. For example, as an example, the NID required to detect VF may be 18 VF intervals in the last 24 consecutive RRIs, 30 VF intervals in 40 consecutive RRIs, or up to 120 VF intervals in 160 consecutive RRIs.
[0103] The arrhythmia detection circuit 92 may be configured to perform other signal analyses to determine whether other detection criteria, such as R-wave morphology criteria, onset criteria, stability criteria, and noise and oversensing rejection criteria, are met before detecting VT or VF based on reaching the NID. To support these additional analyses, the sensing circuit 86 may pass the digitized ECG signal to the control circuit 80 (e.g., from the morphology signal channel 87) for morphology analysis performed by the arrhythmia detection circuit 92 to detect and distinguish cardiac rhythms. The cardiac electrical signal received by the morphology signal channel 87 (and / or the sensing channel 83 and / or the sensing channel 85) may pass through a filter and amplifier, be provided to a multiplexer, and thereafter be converted to a multi-bit digital signal by an analog-to-digital converter, all of which are included in the sensing circuit 86 for storage in the memory 82. The memory 82 may include one or more circular buffers to temporarily store digital cardiac signal segments for analysis performed by the control circuit 80. The control circuit 80 can be a microprocessor-based controller that uses digital signal analysis techniques to characterize the digitized signals stored in the memory 82 to identify and classify the patient's heart rhythm using any of a variety of signal processing methods for analyzing cardiac signals and cardiac event waveforms (e.g., R waves).
[0104] As follows Figure 4 As described, the therapy delivery circuit 84 includes at least one charging circuit and one or more charge storage devices, such as one or more high voltage capacitors for generating high voltage shock pulses for treating VT / VF. The therapy delivery circuit 84 may include a high voltage (HV) therapy circuit 100, which may include an HV charging circuit, an HV holding capacitor, and an HV output circuit operably controlled by a signal from the control circuit 80, for charging and subsequently discharging the high voltage capacitor for CV / DF shock delivery when the control circuit 80 detects VT / VF.
[0105] In some examples, the therapy delivery circuit 84 may include a low voltage (LV) therapy delivery circuit 102, which may include an LV charging circuit, one or more LV holding capacitors, and an LV output circuit to generate and deliver low voltage cardiac pacing pulses, for example, cardiac pacing pulses having a pacing pulse amplitude of 8V or less, up to 10V, up to 12V, up to 16V, or other maximum voltage amplitude of the LV therapy delivery circuit 102. In some cases, the LV cardiac pacing pulses may be delivered via the ring electrodes 28 and / or 30 (together or in combination with the housing 15) to successfully capture and pace the heart. In some examples, compound cardiac pacing pulses may be delivered by the LV therapy delivery circuit 102 to deliver continuous low voltage cardiac pacing pulses having a relatively long cumulative pulse width (e.g., as an example, up to 6ms to 8ms) to deliver sufficient pulse energy to capture and pace the heart. Methods and apparatus for delivering compound cardiac pacing pulses (sometimes referred to as "stacked pacing pulses") are generally disclosed in U.S. Pat. No. 10,449,362 (Anderson et al.).
[0106] However, in some patients, the cardiac pacing capture threshold may require a pacing pulse amplitude and / or pulse width greater than the maximum pacing pulse amplitude and / or pulse width that can be generated by LV therapy delivery circuitry 102 and delivered via ring electrodes 28 and 30 to successfully capture the heart. The pacing capture threshold and / or other factors (such as the electric field of the pacing electrode vector relative to the patient's heart, current density at the electrode-tissue interface, or auxiliary capture of non-cardiac tissue) may make cardiac pacing via coil electrode 24 and / or coil electrode 26 desirable or preferred.
[0107] Cardiac pacing pulses using high surface area coil electrodes 24 and 26 for delivering CV / DF shock pulses can successfully capture the heart without the limitations that may be associated with delivering cardiac pacing pulses from LV therapy circuit 102 via relatively small surface area ring electrodes 28 and 30 implanted at an extracardiac location. However, delivery of cardiac pacing pulses via HV therapy circuit 100 may prematurely drain current from power supply 98. As described below in conjunction with Figure 4As further described, the HV output circuit included in the HV therapy circuit 100 may include switches and / or other components that require relatively high operating currents to enable delivery of CV / DF shocks. CV / DF shocks are typically delivered relatively infrequently, such that the current required to operate the HV output circuit is acceptable over the useful life of the ICD 14. However, a higher number of cardiac pacing pulses and / or more frequent cardiac pacing than CV / DF shocks may be required during the life of the ICD 14, for example, to deliver bradycardia pacing, ATP, post-shock pacing, etc. Therefore, the relatively high current required to operate the HV output circuit of the HV therapy circuit 100 to deliver cardiac pacing pulses via the coil electrodes 24 and 26 may unacceptably shorten the useful life of the power supply 98.
[0108] Thus, therapy delivery circuit 84 may include operating circuitry, referred to herein as "bypass circuitry," to conduct pacing pulse signals from a cardiac pacing voltage source to the coil electrode terminals while bypassing at least a portion of the HV output circuit components that require relatively high operating currents to deliver CV / DF shock pulses to the coil electrode terminals. In some examples, such as the following in conjunction with Figure 4 As described, the therapy delivery circuit 84 includes a voltage regulator configured to step down and / or maintain the voltage amplitude of the charged HV capacitor to form cardiac pacing pulses having a pacing voltage amplitude that is relatively low in voltage amplitude compared to the CV / DF shocks delivered by the HV therapy delivery circuit 84 but which may be higher in voltage amplitude than the cardiac pacing pulses generated by the LV therapy circuit 102. The voltage regulator and bypass circuit used as a cardiac pacing voltage source may be controlled by the therapy control circuit 94 to deliver cardiac pacing pulses via the coil electrodes 24 and / or 26 having a voltage amplitude between the voltage amplitude of the CV / DF shocks generated and delivered by the HV therapy circuit 100 and the voltage amplitude of the cardiac pacing pulses generated and delivered by the LV therapy delivery circuit 102.
[0109] As further described below, the bypass circuit can be controlled by the therapy control circuit 94 to couple a cardiac pacing voltage source to the coil electrodes 24 and / or 26 to deliver cardiac pacing using a portion of the HV output circuit while bypassing or excluding at least one high current component of the HV output circuit to reduce the operating current required to deliver cardiac pacing pulses via the coil electrodes 24 and / or 26 as compared to delivering cardiac pacing pulses via the HV output circuit according to the CV / DF output path. In some examples, the bypass circuit can be configured to receive an output voltage signal from the LV therapy delivery circuit 102 to deliver cardiac pacing pulses via the coil electrodes 24 and / or 26 using a cardiac pacing path that includes a portion of the HV output circuit but excludes the high operating current components of the HV output circuit. The therapy control circuit 94 of the control circuit 80 can select a cardiac pacing voltage source, pacing voltage amplitude, pulse width, polarity, and other characteristics of the cardiac pacing pulses that can be based on programmed values stored in the memory 82.
[0110] In some examples, in addition to being configured to deliver therapeutic electrical stimulation pulses to the patient's heart under the control of control circuit 80, therapy delivery circuit 84 can be controlled to receive electrical stimulation pulses from external device 40 (eg, during ICD implantation or subsequent testing procedures) via telemetry circuit 88. Figure 1A ) when a programmed command is received by the device to deliver electrical stimulation pulses for inducing tachyarrhythmias, such as T wave shocks or induction pulse trains.
[0111] The telemetry circuit 88 includes a transceiver and an antenna for communicating with the external device 40 (in the example of FIG. Figure 1A 80). Control parameters used by control circuitry 80 to sense cardiac event signals, detect arrhythmias, and control therapy delivery may be programmed into memory 82 via telemetry circuitry 88. Under control of control circuitry 80, telemetry circuitry 88 may receive downlink telemetry from external device 40 and transmit uplink telemetry to the external device. Telemetry circuitry 88 may receive, for example, a pacing voltage amplitude selected and programmed by a user interacting with external device 40. Therapy control circuitry 94 may select a cardiac pacing voltage source and a pacing output path based on the pacing voltage amplitude, and transmit control signals to therapy delivery circuitry 84 to control delivery of pacing pulses by therapy delivery circuitry 84 based on the selected pacing parameters.
[0112] Figure 41 is a conceptual diagram of circuits that may be included in therapy delivery circuitry 84 of ICD 14 according to some examples. The therapy delivery circuitry 84 includes an HV charging circuit 152 configured to charge one or more HV holding capacitors 162 to deliver CV / DF shocks to coil electrodes 24 and / or 26 and / or housing 15 via an HV output circuit 160. HV charging circuit 152, HV holding capacitors 162, and HV output circuit 160 may also be included in Figure 3 In the HV treatment circuit 100 shown.
[0113] In response to control circuit 80 detecting a need for CV / DF shock therapy based on analysis of cardiac electrical signals sensed by sensing circuit 86, HV holding capacitor 162 may be charged by HV charging circuit 152 to a shock voltage amplitude to deliver a CV / DF shock under the control of control circuit 80. HV charging circuit 152 may include a transformer to step up power supply 98 ( Figure 3 ) in order to achieve charging the HV holding capacitor 162 to a voltage greater than the battery voltage. The HV charging circuit 152 may include one or more transformers, switches, diodes, and / or other devices for operating to charge the HV holding capacitor 162 to a desired voltage.
[0114] The control circuit 80 may transmit a charging signal to the HV charging circuit 152 to initiate charging and receive a feedback signal from the HV charging circuit 152 to determine when the HV holding capacitor 162 is charged to a shock voltage amplitude (e.g., corresponding to a programmed CV / DF shock energy, which may be selected or set to a nominal defibrillation energy (e.g., 20 joules or greater) based on a defibrillation threshold test). A charge completion signal may be transmitted from the control circuit 80 to the HV charging circuit 152 to terminate charging of the HV holding capacitor 162 in response to determining that the HV holding capacitor 162 is charged to a desired voltage.
[0115] Although in Figure 4 100 , the HV holding capacitor 162 is shown as a single capacitor, but it should be understood that a combination of capacitors can be configured to act as an HV holding capacitor that can be charged to the shock voltage amplitude. For example, two or more HV capacitors can be provided in the HV therapy circuit 100, which have an effective capacitance of 100 microfarads to 200 microfarads, or, for example, about 140 microfarads to 160 microfarads. For example, the HV capacitor can be charged to hold 750V to 800V in order to deliver a CV / DF shock having a pulse energy of 5 joules or more, and more typically 20 joules or more.
[0116] A CV / DF shock may be delivered to the heart by discharging HV holding capacitor 162 under control of control circuit 80, according to a signal communicated to HV output circuit 160, for example, via a control bus from therapy control circuit 94. HV output circuit 160 includes a switching circuit, which may be in the form of an H-bridge including high-side switches 180a to 180c and low-side switches 182a to 182c, which are biased from a non-conductive state (e.g., off or disabled) to a conductive state (e.g., on or enabled) by a signal from therapy control circuit 94 of control circuit 80.
[0117] The high-side switches 180a to 180c may each include one or more electronic switching devices. In some examples, the high-side switches 180a to 180c may each include an anode gated thyristor (AGT), a metal oxide semiconductor field effect transistor (MOSFET), an insulated gate bipolar transistor (IGBT), a MOS controlled thyristor (MCT), a silicon controlled rectifier (SCR), or other switching devices or combinations of switching devices with high voltage ratings. The high-side switches 180a to 180c are typically high-rated voltage switches that require high operating currents to bias the switches from a non-conducting or off state to a conducting or on state so that current leakage from the HV holding capacitor 162 can be minimized when the high-side switches 180a to 180c are not enabled. The high-side switches 180a to 180c may be charge-coupled devices (e.g., AGTs) that can be controlled without the need for bootstrapping. One or a combination of high-side switches 180a to 180c is turned on and maintained in the on state to conduct current from the HV capacitor 162 to the electrode terminals 124, 126, or 115, which are respectively coupled to the coil electrode 24, coil electrode 26, or housing 15 selected as the CV / DF cathode electrode. Different ones of the coil electrode 26, coil electrode 24, or housing 15 can be selected as the return anode electrode by turning on a selected one of the low-side switches 182a, 182b, or 182c, which are coupled to the corresponding electrode terminals 124, 126, 115 of the selected anode electrode.
[0118] A relatively high current trigger signal may be delivered from the control circuit 80 to turn on the selected high-side switch 180a, 180b, or 180c to begin discharging the HV capacitor 162 for shock delivery. During the discharge of the HV capacitor 162 through the selected shock delivery pathway, the high current flowing through the enabled high-side switch 180a, 180b, or 180c maintains the switch in the on state until the switch 180a, 180b, or 180c is disabled or "turned off" by the control circuit 80. The high-side switches 180a-180c may require a relatively high trigger current of, for example, 100 mA to 200 mA from the control circuit 80 to bias the switch to the on state.
[0119] The low-side switches 182a to 182c may each include one or more switching devices that may be implemented as SCRs, IGBTs, MOSFETs, MCTs, and / or other components or combinations of components. The low-side switches 182a, 182b, 182c are biased to an on state according to a control signal from the therapy control circuit 94 of the control circuit 80 to select a return path through the anode electrode selected from the coil electrodes 24, 26 or the housing 15. The low-side switches 182a to 182c may be relatively low-impedance switches to minimize losses during defibrillation and may be turned on by a relatively low current control signal (e.g., less than 10 mA) from the control circuit 80.
[0120] The switches 180a to 180c and the switches 182a to 182c are controlled by the control circuit 80 (e.g., by Figure 3 The signal received by the treatment control circuit 94 shown in the figure is controlled to be turned on or off at the appropriate time to deliver CV / DF electric shock. For example, one of the switches 180a, 180b or 180c can be turned on simultaneously with one of the switches 182a, 182b or 182c, without turning on two switches "a", "b" or "c" across a given electrode terminal 124, 126 or 115 respectively at the same time. For example, in order to deliver a biphasic CV / DF electric shock using the coil electrode 24 and the housing 15, switches 180a and 182c can be turned on to deliver the first phase of the biphasic electric shock pulse. Before the HV capacitor 162 is fully discharged, switches 180a and 182c are turned off after the first phase, and switches 180c and 182a are turned on to deliver the second phase of the biphasic pulse. In this example, when the coil electrode 26 is not selected for the CV / DF electric shock delivery vector, switches 180b and 182b remain turned off or in a non-conducting state. In other examples, coil electrode 26 may be included instead of coil electrode 24, or selected to function as a cathode electrode or an anode electrode simultaneously with coil electrode 24. Examples of circuits and techniques for delivering CV / DF shock pulses via HV output circuits are generally disclosed in U.S. Patent 10,159,847 (Rasmussen et al.).
[0121] When a cardiac pacing pulse is required and the pacing capture threshold is very high, e.g., greater than 16 V, greater than 20 V, greater than 30 V, or greater than 40 V, control circuit 80 can control HV charging circuit 152 to charge HV capacitor 162 to a programmed pacing voltage amplitude that is less than the voltage required for CV / DF shock delivery. Relatively high voltage cardiac pacing pulses can be delivered via HV output circuit 160 by applying control signals to selected high-side switches 180 a to 180 c and selected low-side switches 182 a to 182 c as needed to discharge HV capacitor 162 via a selected pacing electrode vector including coil electrodes 24 and / or 26 and / or housing 15. However, the current required to bias the selected switches 180a, 180b, and / or 180c from the non-conducting state to the conducting state and the cardiac pacing pulses delivered using a sufficiently high voltage amplitude to maintain the selected high-side switches 180a, 180b, and / or 180c in the conducting state during the cardiac pacing pulses may prematurely deplete the power supply 98. The relatively high voltage pacing pulses may not be well tolerated by the patient. Thus, whenever possible (e.g., when the capture threshold falls in the middle or relatively low voltage amplitude range), the control circuit 80 can select the cardiac pacing voltage source of the therapy delivery circuit 84 to deliver cardiac pacing via a cardiac pacing output path that is more power efficient than the output path of the high-side switches 180a to 180c including the HV output circuit 160.
[0122] In some cases, as further described below, in response to control circuit 80 detecting a need for cardiac pacing, HV holding capacitor 162 may be charged to a voltage less than a voltage required to deliver a CV / DF shock to generate a rail voltage that is regulated by voltage regulator 154 to provide a pacing voltage source for delivering cardiac pacing pulses via a portion of HV output circuit 160. When the pacing capture threshold and the corresponding pacing voltage amplitude are above the maximum voltage output that can be generated by LV therapy circuit 102, HV holding capacitor 162 may be charged to a voltage amplitude for generating cardiac pacing pulses under the control of control circuit 80.
[0123] Bypass circuit 156 can be controlled by control circuit 80 to pass current from the cardiac pacing voltage source to electrode terminals 124, 126 and / or 115, which are respectively coupled to coil electrodes 124 and 126 and housing 115. When bypass circuit 156 is enabled by control circuit 80, high-side switches 180a to 180c can be disabled by control signals from control circuit 80 to select a cardiac pacing output path that excludes a first portion of the HV output circuit 160 that requires a relatively high operating current and includes a second portion of the HV output circuit 160 that requires a relatively low operating current. The first portion may include high-side switches 180a to 180c used during CV / DF shock delivery. The second portion may include any one of low-side switches 182a, 182b and / or 182c, which require a relatively lower operating current than high-side switches 180a to 180c and provide a return current path during pacing pulse delivery.
[0124] In some examples, therapy delivery circuit 84 may include a cardiac pacing voltage source including voltage regulator 154 configured to pass voltage output signal 164 to bypass circuit 156 to deliver cardiac pacing pulses to coil electrodes 24 and / or 26 without turning on any of high-side switches 180a-180c of HV output circuit 160. When control circuit 80 enables bypass circuit 156, switches 180a-180c requiring high operating current are bypassed in the pacing output path.
[0125] The charging of the HV capacitor 162 by the HV charging circuit 152 can be controlled by the control circuit 80 to generate a rail voltage (e.g., 10V to 50V or approximately 20V to 40V) to provide a positive DC voltage that can be used to power various components of the therapy delivery circuit 84. The voltage regulator 154 can receive the rail voltage and provide a voltage regulated output signal 164 having a desired cardiac pacing pulse voltage amplitude to the bypass circuit 156, which desired cardiac pacing pulse voltage amplitude can be stepped down from the rail voltage. For example, the HV charging circuit 152 can be controlled by the control circuit 80 to charge the HV capacitor 162 to 16V, 18V, 20V, 30V, 40V, 50V, or higher to generate a rail voltage that is at least equal to or greater than the desired cardiac pacing pulse voltage amplitude. The voltage regulator 154 can be configured to regulate the rail voltage to a programmed pacing pulse voltage amplitude, such as 15V to 30V or approximately 16V to 20V as an example. In some examples, voltage regulator 154 may be configured to set the voltage amplitude of output signal 164 to a fixed value, such as 16 V to 18 V. In other examples, voltage regulator 154 may receive a control signal from control circuit 80 to adjust the amplitude of output signal 164 to a programmed pacing pulse voltage amplitude.
[0126] The bypass circuit 156 may include a switch circuit that may be enabled by a control signal from the control circuit 80 and maintained in an on state by a current that flows from the voltage regulator 154 through the bypass circuit 156 to the selected cardiac pacing cathode terminal 124, 126, and / or 115 and returns via a selected cardiac pacing anode terminal (a different terminal of the terminals 124, 126, or 115 that is not selected as the cathode). The return anode may be selected by the control circuit 80 via a control signal that turns on one of the low-side switches 182a to 182c of the HV output circuit 160. The therapy control circuit 94 of the control circuit 80 may control the pacing pulse polarity and pacing pulse width based on the control signal delivered to the switch device and / or switches 182a to 182c of the bypass circuit 156.
[0127] Bypass circuit 156 may include a plurality of switches (eg, FETs or other solid-state semiconductor devices) that require a relatively lower operating current to turn on and remain in an on state than the current required to operate HV output circuit high-side switches 180a to 180c. Figure 5 As described, bypass circuit 156 may include multiple "channels," each of which includes one or more switching devices to selectively couple voltage output signal 164 (also referred to herein as a "pacing pulse signal") to a desired pacing cathode electrode terminal among terminals 124, 126, and 115. Control circuit 80 may control the switches of bypass circuit 156 and low-side switches 182a to 182c of HV output circuit 160 to deliver single-phase, biphasic, or other multi-phase cardiac pacing signals.
[0128] To initiate a pacing pulse, control circuit 80 may turn on a selected one of low-side switches 182a, 182b, or 182c of bypass circuit 156 and HV output circuit 160 upon expiration of a pacing escape interval (e.g., a lower rate interval, a hysteresis interval, an asystole detection interval, a post-shock pacing interval, or an ATP interval), which may be timed out by timing circuit 90 or by a timer included in therapy control circuit 94. In some instances, control circuit 80 may initiate delivery of a cardiac pacing pulse signal via a portion of bypass circuit 156 and HV output circuit 160 that includes at least one of low-side switches 182a to 182c (and excludes switches 180a to 180c) in response to detection of a pacing triggering event (e.g., a lead pacing pulse for synchronizing an ATP sequence or a sensed R-wave for triggering a backup safety pacing pulse).
[0129] When the pacing pulse width expires, for example, as determined by therapy control circuit 94 of control circuit 80 or by a timer included in therapy delivery circuit 84, bypass circuit 156 (and any enabled low-side switches 182a to 182c) can be disabled to terminate the cardiac pacing pulse. Bypass circuit 156 and selected ones of low-side switches 182a to 182c can be re-enabled by a control signal from control circuit 80, for example, upon expiration of the next pacing escape interval or upon detection of the next triggering event based on voltage output signal 164 of voltage regulator 154, to deliver the next cardiac pacing pulse signal.
[0130] Current flowing from voltage regulator 154 through selected switches included in bypass circuit 156 and through a cardiac pacing output path including a return path through at least one of HV output circuit low-side switches 182a, 182b, or 182c maintains enabled low-side switches 182a, 182b, and / or 182c in an on state because switches 182a to 182c require less operating current than HV output circuit high-side switches 180a to 180c. In this manner, cardiac pacing pulses may be delivered using coil electrodes 24 and 26 at less current than would be required if cardiac pacing pulses were delivered to electrode terminals 124 or 126 and corresponding coil electrodes 24 or 26 via high-side switches 180a or 180b of the first portion of HV output circuit 160.
[0131] In some examples, housing 15 is used as an active can electrode only during CV / DF shock delivery. In this case, the cardiac pacing pulses delivered when bypass circuit 156 is enabled are delivered via a pacing electrode vector between coil electrodes 24 and 26. In other examples, housing 15 may be used as a return anode, where either or both of coil electrodes 24 and 26 are selected as cathode electrodes. In yet other examples, housing 15 may be used as a pacing cathode electrode, where either or both of coil electrodes 24 and 26 are selected as return anode electrodes.
[0132] By eliminating the high-side switches 180a to 180c of the HV output circuit 160 from the cardiac pacing output path, cardiac pacing pulses can be delivered via the coil electrodes 24 and / or 26 more efficiently (lower operating current), potentially at a higher rate, and without amplitude drop (amplitude drop can occur when high current flows out of the HV holding capacitor 162) as compared to when the cardiac pacing pulses are delivered to the coil electrodes 24 and / or 26 via the high-side switches 180a and / or 180b of the first portion of the HV output circuit 160. The life of the power supply 98 can be extended by generating a pacing pulse signal from a pacing voltage source including a voltage regulator 154 and delivering the pacing pulse signal to selected coil electrode terminals 124 and / or 126 using a bypass circuit 156 to utilize a relatively low operating current portion of the HV output circuit 160 (e.g., low-side switches 182a and 182b), as compared to delivering pacing pulses by discharging the HV holding capacitor 162 via the high-side switches 180a to 180c and the low-side switches 182a to 182c of the HV output circuit 160.
[0133] Figure 5 1 is a diagram of a bypass circuit 156 according to some examples. The bypass circuit 156 may include a circuit for bypassing a cardiac pacing pulse signal from a cardiac pacing voltage source (e.g., a voltage regulator 162 ( Figure 4 )) to a plurality of channels for delivering pacing electrode vectors, the pacing electrode vectors including at least one high surface area, coil electrode 24 or 26, which may also be selected for delivering CV / DF shocks. In the illustrated example, three bypass circuit channels are shown to couple voltage signals 164 from voltage regulator 162 to cardiac pacing electrode vectors selected from coil electrodes 24, 26, and housing 15. Each channel may include one or more switches for coupling voltage signals 164 to the selected coil electrode 24, coil electrode 26, or housing 15. In the illustrated example, each channel includes a pair of switches, such as switches 170a and 170b (collectively referred to as channels 170) coupled to electrode terminal 124, switches 172a and 172b (collectively referred to as channels 172) coupled to electrode 126, and switches 174a and 174b (collectively referred to as channels 174) coupled to electrode terminal 115.
[0134] The two switches included in a given channel 170, 172, or 174 can each be individually turned on by a control signal received from the control circuit 80 to couple the voltage signal 164 from the voltage regulator 154 to the corresponding coil electrode terminal 124, coil electrode terminal 126, or shell electrode terminal 115. In a disabled or off state, the first switch 170a, 172a, and 174a of a given channel prevents the amplitude voltage signal 164 from leaking through the second switch 170b, 172b, and 174b, which can be triggered to turn on and / or maintain in an on state by a lower current than the first switch 170a, 172a, and 174a. In one example, the first switch 170a, 172a, and 174a can be a p-channel MOSFET with a rated voltage of 10V to 30V, such as a p-channel MOSFET with a rated voltage of 20V.
[0135] The second switches 170b, 172b, and 174b can be solid-state semiconductor switch devices that provide high voltage protection for the circuits and components of the ICD 14. For example, the second switches 170b, 172b, and 174b can include one or more FETs, diodes, or other devices that require a relatively low trigger current or do not require a trigger current to bias to an on state. In one example, the second switches 170b, 172b, and 174b can be implemented as approximately 10 ohm MOSFETs that conduct the pacing current from the MOSFET body to the drain through a parasitic diode. When the patient is exposed to high voltage, for example, during CV / DF shock delivery by the ICD 14 or by an external defibrillator, current can be induced on the conductor extending within the lead 16. The current flowing into the bypass circuit 156 and other ICD circuits is blocked by the second switches 170b, 172b, and 174b to protect the ICD circuits during exposure to high voltage. Each channel 170, 172, and 174 can be biased into an on state using a relatively low current (e.g., less than 10 microamperes or even less than 1 microampere) to enable cardiac pacing pulses to be delivered to the selected electrode terminal 124, 126, or 115 in a power-efficient manner for cardiac pacing using the coil electrodes 24 and 26.
[0136] In some examples, ICD 14 may be configured to deliver cardiac pacing pulses in a selected one of an upper range, a middle range, and a lower range of pacing pulse voltage amplitudes using coil electrodes 24 and / or 26, for example based on a cardiac pacing capture threshold. Figure 4As described above, the control circuit 80 can control the HV holding capacitor 162 to charge to a cardiac pacing pulse voltage amplitude in an upper range, for example, greater than 16V, greater than 20V, greater than 30V or greater than 40V, and control the HV output circuit 160 to use the H-bridge switching circuit of the output circuit 160 to deliver a cardiac pacing pulse with a voltage amplitude in the upper range.
[0137] When the pacing capture threshold is less than the upper range and falls within the middle range, the control circuit 80 can control the HV holding capacitor to charge to the middle voltage to enable the voltage regulator 154 to generate a cardiac pacing pulse signal as a voltage output signal 164 to the bypass circuit 156 to deliver a cardiac pacing pulse with a voltage amplitude in the middle range, for example, up to a maximum voltage amplitude available from the voltage regulator 154, which can be up to 16V, up to 18V, up to 20V, up to 30V, or up to 40V, as examples. Figure 5 As shown in FIG. 1 , the bypass circuit channels 170, 172, or 174 can deliver an intermediate voltage amplitude pacing pulse signal to the selected electrode terminals 124, 126, or 115 for delivery of pacing pulses using at least one of the coil electrodes 24 and / or 26. The voltage signal 164 delivered from the voltage regulator 154 to the bypass circuit 156 is referred to as an “intermediate voltage” cardiac pacing pulse signal because the intermediate voltage amplitude pacing pulse signal is delivered to the LV therapy circuit 102 ( Figure 3 ) but not greater than the voltage amplitude available from voltage regulator 154, voltage regulator 154 may be used as a cardiac pacing pulse voltage source. When the pacing capture threshold is greater than the voltage amplitude available from voltage regulator 154, HV therapy circuit 100 may deliver pacing pulses in the upper range via HV output circuit 160 using charged HV capacitor 162 as a cardiac pacing pulse voltage source.
[0138] When the pacing capture threshold is within the lower range, bypass circuit 156 can receive a cardiac pacing pulse signal from a cardiac pacing voltage source that is capable of generating a pacing pulse signal having a voltage amplitude up to a maximum voltage amplitude of the lower range, such as up to 8V, up to 10V, up to 12V, or up to 16V, as non-limiting examples. Control circuit 80 can enable one of switches 165a, 165b, or 165c to conduct the lower range cardiac pacing pulse signal from the lower range cardiac pacing voltage source to bypass circuit 156. As described below in conjunction with Figure 6 As described above, the LV treatment circuit 102 (in Figure 3170a, 172a, or 174a and the second switch 170b, 172b, or 174b of the selected channel of the bypass circuit 156, respectively, can be configured to receive the cardiac pacing pulse signal from the LV therapy circuit 102 to pass the relatively low-amplitude cardiac pacing pulse signal to the selected pacing cathode terminal 124, 126, or 115 via the second switch 170b, 172b, or 174b of the given channel. In this way, the bypass circuit 156 can be enabled to deliver cardiac pacing pulse signals in the middle range or the lower range of pacing pulse voltage amplitudes using the coil electrodes 24 and / or 26 (e.g., in a bipolar pair), wherein the low-side switches 182a to 182c of the HV output circuit 160 are used to provide a return current path.
[0139] Figure 6 8 is a conceptual diagram of a therapy delivery circuit 84 according to another example. As described above, therapy delivery circuit 84 may include LV therapy circuit 102, which may include LV charging circuit 132 and LV output circuit 140. LV charging circuit 132 may include one or more charge pumps 134 to charge one of LV holding capacitors 142 or 146 to a pacing voltage amplitude up to a multiple of the battery voltage of power supply 98. Charge pump 134 is labeled as an "Nx" charge pump because it is capable of charging holding capacitors 142 and 146 to N times (Nx) the battery voltage of power supply 98, where N may be equal to any selected multiple of the battery voltage, for example, up to two, three, or four times the battery voltage. The state machine of control circuit 80 may use the multiple of the battery voltage of power supply 98 to control the charging of LV holding capacitor 142 or 146 to a programmed pacing voltage amplitude. As an example, LV holding capacitor 142 or 146 may have a capacitance of 50 microfarads or less or as low as 10 microfarads or less.
[0140] In some cases, one of the ring electrodes 28 or 30 can be selected as a pacing cathode electrode for delivering cardiac pacing pulses. The capacitor selection switch 143 or 147 can be biased to an on state by a control signal from the control circuit 80 to charge the selected LV holding capacitor 142 or 146 through the charge pump 134 to achieve a desired pacing pulse amplitude in the lower range of the pulse voltage amplitude. By turning on the electrode selection switch 144 or 148 after charging is completed, the charged holding capacitor 142 or 146 can be discharged via the head capacitor 145 or 149, respectively, to deliver a pacing pulse to the selected cathode electrode (e.g., the ring electrode 28 coupled to the electrode terminal 128 or the ring electrode 30 coupled to the electrode terminal 130). The other ring electrode 30 or 28 can be used as a return anode electrode.
[0141] However, when the coil electrode 24 and / or the coil electrode 26 or, in some examples, the housing 15 is selected as a pacing cathode electrode, the control circuit 80 can turn on the corresponding second switch 170b, 172b, or 174b to conduct the low-amplitude cardiac pacing pulse signal received from the LV output circuit 140 via one of the switches 165a, 165b, or 165c to the corresponding electrode terminal 124 and / or 126 (or, in some examples, the housing electrode terminal 115). One of the low-side switches 182a, 182b, or 182c is turned on to provide a return path from the selected pacing anode electrode (e.g., the coil electrode 24, the coil electrode 25, or the housing 15 that is not used as a cathode electrode). The control circuit 80 can select (or the user can program) a cardiac pacing electrode vector that includes the coil electrode 24 and / or the coil electrode 26. LV output circuit 140 can pass a cardiac pacing pulse signal in the lower range of pacing voltage amplitude to bypass circuit 156 via one of switches 165a, 165b, or 165c to deliver a lower voltage pacing pulse via at least one or both of coil electrodes 24 and 26 (or, in some examples, housing 15). In this way, a second portion of HV output circuit 160 (including low-side switches 182a to 182c) can be used to efficiently deliver a lower voltage pacing pulse using coil electrodes 24 and / or 26 without turning on any of high-side switches 180a to 180c.
[0142] Figure 7 is a conceptual diagram of a therapy delivery circuit 84 according to another example. The LV therapy circuit 102 can be configured to generate both a lower range pacing voltage amplitude signal and a mid-range pacing voltage amplitude signal. For example, the LV charging circuit 132 can include a plurality of charge pumps 134 and 136 to generate cardiac pacing pulse signals in the lower range, such as up to 8V, up to 10V, or up to 12V, as an example using a first charge pump 134. The pacing current can be delivered to the bypass circuit 156 from the LV capacitor 142 or 146 charged by the first charge pump 134. The pacing current can be delivered to the bypass circuit 156 at a node between a first switch 170a, 172a, or 174a and a second switch 170b, 172b, and 174b of the bypass circuit channel, respectively, to deliver a cardiac pacing pulse via the coil electrode 24 and / or 26 and / or the housing 15, and connect the selected return electrode using the HV output circuit switches 182a to 182c.
[0143] In some examples, the LV charging circuit 132 can be selected by the control circuit 80 as a cardiac pacing voltage source by enabling multiple charge pumps 134 and 136 to generate cardiac pacing pulse signals received by the bypass circuit 156. The cardiac pacing pulses generated using both the first charge pump 134 and the second charge pump 136 in the cardiac pacing voltage source can have an amplitude in the middle range of pacing pulse voltage amplitudes, for example, between 8V and 30V or between 10V and 30V or between 10V and 20V or between 10V and 16V, as examples, without intending to be limiting. In this case, when the control circuit 80 enables the switch 166, the holding capacitor 168 can be charged by the output of the second charge pump 136. The holding capacitor 168 can have a higher rated voltage than the holding capacitors 142 and 146 but lower than the HV holding capacitor 162. When the capacitor selection switch 166 is enabled by the control circuit 80, the holding capacitor 168 can be charged by the output of the second Mx charge pump 136. The output of second Mx charge pump 136 may charge holding capacitor 168 up to M times (Mx) the output of first Nx charge pump, for a total of MxN times the battery voltage of power source 98. In the illustrative example, first charge pump 134 is a 3x charge pump and second charge pump 136 is a 2x charge pump to provide a pacing voltage signal up to 6 times the battery voltage of power source 98.
[0144] When switch 167 is enabled by control circuit 206 (and switch 166 is disabled), the terminals of holding capacitor 168 can be coupled to bypass circuit 156 when charged to an intermediate pacing voltage amplitude. The pacing voltage signal received by bypass circuit 156 can be delivered through a selected channel 170, 172, or 174 of bypass circuit 156, which includes both a first switch 170a, 172a, or 174a and a second switch 170b, 172b, or 174b of the selected channel. In this example, when control circuit 80 has detected a ventricular tachyarrhythmia, control circuit 80 can control therapy delivery circuit 84 to use LV charging circuit 132 and LV output circuit 140 as cardiac pacing voltage sources to generate and deliver cardiac pacing pulse signals in the middle range or lower range of pacing pulse voltage amplitudes to deliver ATP during charging of HV holding capacitor 162 for CV / DF shock delivery.
[0145] In other examples, therapy delivery circuit 84 can be configured to generate and deliver cardiac pacing pulses having voltage amplitudes in a selected one of a plurality of intermediate ranges to a pacing electrode vector including coil electrodes 24 and / or 26. For example, using first Nx charge pump 134 (which can be a 3x or 4x charge pump as an example), cardiac pacing pulse signals in a lower range of pacing pulse voltage amplitudes (e.g., up to 8V or 10V) can be generated and passed to bypass circuit 156, as shown. Figure 6 and Figure 7 , and as described above. In the event that the first switch 174a, 172a, or 170a is off, a low amplitude signal may be delivered to the bypass circuit 156 to the second switch 170b, 172b, or 174b of the selected channel 170, 172, or 174. Using the combination of the first Nx charge pump 134 and the second Mx charge pump 136, a cardiac pacing pulse signal in a first mid-range (e.g., as an example, above the lower range maximum limit of 8V or 10V and up to the first mid-range maximum limit of 16V to 20V) of pacing pulse voltage amplitude may be generated and delivered to the bypass circuit 156 to the selected channel 170, 172, or 174 including both the first switch channel and the second switch channel (both the "a" and "b" switches) that are turned on.
[0146] When the pacing capture threshold is greater than the first intermediate range maximum limit, the control circuit 80 may control the HV charging circuit 152 to generate a rail voltage that is delivered to the voltage regulator 154 to generate a cardiac pacing pulse signal having a voltage amplitude in a second intermediate range that is greater than the first intermediate range. Figure 4 and Figure 6 ) can deliver a cardiac pacing pulse signal 164 to a selected channel 170, 172, or 174 in an intermediate range having a minimum voltage limit of, for example, 14V, 16V, 18V, or 20V and a maximum voltage limit of, for example, 20V, 30V, 40V, or 50V. If the pacing capture threshold is even higher than the maximum limit of the second intermediate range, the control circuit 80 can control the HV therapy circuit 100 to use the HV output circuit 160 (including the selected high-side switches 180a to 180c and the selected low-side switches 182a to 182c) to generate and deliver a cardiac pacing pulse having a voltage amplitude in the upper range. The upper range can be greater than the maximum limit of the second intermediate range, for example, greater than 20V, greater than 30V, or greater than 40V, and extends to a maximum allowed pacing pulse voltage, for example, 40V or 50V. Thus, the control circuit 80 can select from a plurality of cardiac pacing voltage sources that can have overlapping ranges of pacing voltage amplitudes to cover a wide range of available pacing voltage amplitudes, for example, from 0.5 V to 50 V, which can be delivered via appropriate, power-efficient output paths and using the coil electrodes 24 and 26.
[0147] Although in Figure 71, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 26, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 71, 61, 62, 63, 64, 65, 66, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135 Figure 6 170a, 172a or 174a of the selected channel. As described above, the first switch and the second switch of the selected channel 170, 172 or 174 are both turned on to transmit the first mid-range cardiac pacing pulse signal.
[0148] Figure 8 300 is a flow chart of a method for delivering cardiac pacing pulses by an ICD 14 according to some examples. At block 302, the control circuit 80 may establish a pacing voltage amplitude. The pacing voltage amplitude may be established by performing a pacing capture threshold test. The pacing voltage amplitude may be established as a safety margin greater than a pacing capture threshold determined by a capture threshold test performed by the ICD 14 (e.g., as examples, 0.25V to 5V or 0.5 to 2V). For example, the control circuit 80 may initiate a pacing capture threshold test in response to detecting a loss of capture or according to a daily or other predetermined capture threshold test protocol. The control circuit 80 may control the therapy delivery circuit 84 to deliver cardiac pacing pulses at one or more pulse voltage amplitudes that may be tested during delivery to different pacing electrode vectors (e.g., between coil electrodes 24 and 26, between ring electrode 28 or 30 and coil electrode 24 or 26, or between ring electrodes 28 and 30) to verify that the heart is captured. In some examples, capture may be verified by detecting an evoked response QRS waveform in the cardiac electrical signal sensed by sensing circuit 86 .
[0149] A coil-to-coil pacing electrode vector between coil electrodes 24 and 26 can be used during a pacing capture threshold test, and a pacing pulse voltage amplitude can be set based on a determined capture threshold, which is the lowest voltage amplitude for a given pulse width that successfully causes myocardial depolarization. In other examples, a plurality of pacing electrode vectors can be selected from the available electrodes 24, 26, 28, 30, and 15. The pacing electrode vector associated with the lowest pacing capture threshold can be identified and selected to deliver a cardiac pacing pulse, wherein the pacing voltage amplitude is established to be greater than the pacing capture threshold by a safety margin.
[0150] In other examples, the control circuit 80 establishes the pacing voltage amplitude based on a user-programmed value received via the telemetry circuit 88, which can be stored in the memory 82. In other examples, the pacing voltage amplitude can be a default or nominal pacing amplitude stored in the memory 82. Based on the pacing voltage amplitude established at block 302, the control circuit 80 can select a cardiac pacing voltage source and a cardiac pacing output path at block 304.
[0151] The control circuit 80 can compare the established pacing voltage amplitude to a lower range, a middle range (or a plurality of middle ranges), and an upper range of pacing voltage amplitudes. The lower range, the middle range, and the upper range of pacing voltage amplitudes can be predefined and stored in the memory 82. The lower range, the middle range, and the upper range of pacing voltage amplitudes correspond to the maximum pacing voltage amplitudes that can be obtained from a given cardiac pacing voltage source. For example, referring to Figure 6 , the LV charging circuit 132 can be capable of generating a cardiac pacing pulse signal in the lower range, e.g., up to a maximum value of 8V to 10V, which can include a composite pacing pulse as generally disclosed in U.S. Patent No. 10,449,362 (Anderson et al.), incorporated above. The voltage regulator 154 can be capable of passing the voltage signal 164 to the bypass circuit 156 as a cardiac pacing pulse signal having an amplitude in the mid-range, e.g., greater than the maximum limit of the lower range (the maximum voltage available from the LV therapy circuit 102) and up to 20V, up to 30V, or up to 40V in various examples. In other examples, the second charge pump 136 included in the LV therapy circuit 102 can be configured to pass the voltage signal 164 to the bypass circuit 156 as a cardiac pacing pulse signal having an amplitude in the mid-range. Figure 7 14. The HV charging circuit 152 that charges the HV capacitor 162 may be capable of generating cardiac pacing pulses in an upper range that is higher than the maximum limit of the voltage signal 164 output by the voltage regulator 154 (e.g., greater than 20V, greater than 30V, or greater than 40V). Other examples of pacing voltage amplitude ranges are described above, for example, in conjunction with Figures 4 to 7 describe.
[0152] Thus, the control circuit 80 can select a cardiac pacing voltage source to be received from the LV output circuit 140 (utilizing the LV charging circuit 132) for a pacing voltage amplitude in the lower range, select a cardiac pacing voltage source to be received from the voltage regulator 154 (utilizing the HV charging circuit 152 and the HV holding capacitor 162) or the second charge pump 136 of the LV charging circuit 132 and the LV output circuit 140 when the pacing voltage amplitude is in the middle range, or select a cardiac pacing voltage source to be received from the HV charging circuit 152 and the HV capacitor 162 when the pacing voltage amplitude is in the upper range. Thus, the cardiac pacing voltage sources of the therapy delivery circuit 84 can include a plurality of selectable cardiac pacing voltage sources capable of generating pacing pulses within different voltage amplitude ranges.
[0153] At block 304, the control circuit 80 selects a pacing output path based at least in part on the selected voltage source. The pacing output path may be selected based on the pacing voltage amplitude and the associated pacing pulse voltage source. In some cases, the pacing path is selected in part because it is the most tolerable for the patient and within the limitations and capabilities of the circuitry of the pacing output path. In some cases, the control circuit 80 may select the pacing voltage source and output path at block 304 based on the pacing therapy being delivered.
[0154] For example, if the control circuit 80 detects VT / VF and is controlling the therapy delivery circuit 84 to deliver ATP during the charging of the HV capacitor 162 for shock delivery, the control circuit 80 may select the highest available intermediate cardiac pacing voltage source that does not utilize the HV capacitor 162. For example, the control circuit 80 may select the output of the second charge pump 136 to charge the holding capacitor 168, which may be coupled to a selected channel of the bypass circuit 156 to deliver ATP pulses in the mid-range of pacing pulse voltage amplitudes. Delivering ATP pulses in the mid-range promotes a high probability of capturing the myocardium via the coil-to-coil pacing electrode vector. ATP delivered via the coil-to-coil pacing electrode vector using ATP pulses having voltage amplitudes in the mid-range generated by the second charge pump 136 during the charging of the HV capacitor can terminate the VT / VF episode, thereby avoiding the need for CV / DF shock delivery.
[0155] The control circuit 80 can select the output of the voltage regulator 154 or the second charge pump 136 (and the holding capacitor 168) coupled to the selected channel of the bypass circuit 156 to deliver a post-shock pacing pulse or pacing in response to the detection of cardiac arrest. Pacing pulses having voltage amplitudes that promote high confidence of successful myocardial capture via the coil-to-coil pacing electrode vector using at least an intermediate pacing voltage amplitude can avoid or prevent cardiac arrest. During the post-shock time interval or when the control circuit 80 detects cardiac arrest, the HV charging circuit 152 can be used to charge the HV capacitor 162 to a voltage less than the CV / DF shock voltage to enable the voltage regulator 154 to become the cardiac pacing voltage source during post-shock pacing.
[0156] At other times, for example, when bradycardia pacing is delivered at a lower rate to provide ventricular rate support, the control circuit 80 may select the output of the first charge pump 134 to charge the LV holding capacitor 142 or 146 and deliver cardiac pacing pulses within the lower voltage amplitude range via the LV output circuit 140 or via the bypass circuit 156 and low-side switches 182a to 182c to provide coil-to-coil pacing. Bradycardia pacing at a programmed lower pacing rate may occur over a longer period of time than ATP or post-shock pacing, and thus may be better tolerated by the patient when the LV therapy circuit 102 is used to deliver pacing pulses within the lower voltage amplitude range of pacing pulses, which may include compound pacing pulses as described in the above-incorporated U.S. Patent No. 10,449,362 (Anderson et al.).
[0157] Thus, control circuit 80 may select different cardiac pacing pulse voltage sources and pacing output paths when pacing is delivered to treat a cardiac rhythm that is not immediately life-threatening and / or for a duration that may be longer than the voltage source and output path selected by control circuit 80 when the cardiac rhythm is considered more immediately life-threatening and / or when delivered for a relatively shorter duration (fewer total cardiac pacing pulses).
[0158] When the HV charging circuit 152 and the HV capacitor 162 are selected as the pacing voltage source, for example, due to the pacing voltage amplitude in the upper range, the control circuit 80 selects the HV output circuit 160 as the pacing output path at box 304. In this case, at box 306, the control circuit 80 transmits a control signal to the HV therapy circuit 100 to control the delivery of one or more pacing pulses at box 308 by charging the HV capacitor 162 to the pacing voltage amplitude and turning on the selected combination of the high-side switches 180a to 180c and the low-side switches 182a to 182c of the HV output circuit 160 at the appropriate time to deliver the pacing pulses via the coil electrodes 24 and 26 or one of the coil electrodes 24 or 26 and the housing 15.
[0159] When voltage regulator 154 is selected as the pacing voltage source because the pacing voltage amplitude is in the mid-range and / or based on the pacing therapy being delivered, control circuit 80 selects the output path to include bypass circuit 156 and HV output circuit switches 182a to 182c, excluding high-side switches 180a to 180c of HV output circuit 160. At block 306, control circuit 80 enables the pacing output by transmitting a control signal to HV charging circuit 152 to charge HV capacitor 162 to a voltage equal to or greater than the pacing voltage amplitude to establish a positive rail voltage through voltage regulator 154, which can be stepped down to the pacing voltage amplitude as needed. The control circuit 80 communicates control signals to the bypass circuit 156 and the HV output circuit 160 to bias the bypass circuit 156 and selected ones of the HV output circuit low-side switches 182a to 182c in a conductive state at appropriate times to enable delivery of pacing pulses to the coil electrodes 24 and 26 or at least one of the coil electrodes 24 or 26, for example, using the housing 15 as a return electrode. One or more pacing pulses may be delivered at block 308 in accordance with pacing therapy control parameters using the voltage regulator 154 as a pacing pulse voltage source and selected channels of the bypass circuit 156, as described above, to exclude the high-side switches 180a to 180c of the HV output circuit 160.
[0160] When the LV output circuit 134 (using the LV charging circuit 132) is selected as the pacing voltage source, the control circuit 80 can select the bypass circuit 156 and the low-side switches 182a to 182c of the HV output circuit 160 coupled to the coil electrodes 24 and / or 26 as the cardiac pacing output path. In some cases, the output from the second charge pump 136 in the middle range of the pacing voltage amplitude can be passed to the bypass circuit, and both the first switch and the second switch of the selected channel of the bypass circuit 156 can be biased to be turned on to conduct the pacing current to the corresponding pacing electrode terminal. In other cases, the first switch of each channel of the bypass circuit 156 can be maintained in a non-conducting state. The low voltage cardiac pacing pulse signal can be received from the LV therapy circuit 102 through the bypass circuit 156 at the node between the first switch and the second switch of the selected channel of the bypass circuit 156 to conduct the pacing pulse signal to the selected electrode terminal. The return path is selected by enabling one of the low side HV output circuit switches 182a-182c to deliver pacing pulses via one or both coil electrodes 24 and 26. In some cases, the LV output circuit 140 coupled to the ring electrodes 28 and / or 30 may be selected as the pacing output path without using the coil electrodes 24 and 26 or any portion of the HV output circuit.
[0161] The pacing output path can be predetermined to be via the bypass circuit 156 and a portion of the HV output circuit 160 such that at least one coil electrode 24 or 26 is included in the pacing output path of all pacing voltage sources. In other examples, when the LV charging circuit 132 provides a cardiac pacing pulse signal to deliver pacing pulses within the lowest range of pacing voltage amplitudes, the pacing output path can be predetermined to be via the LV output circuit 140 using the ring electrodes 28 and / or 30. When the voltage regulator 154 or the second charge pump 136 is selected as a voltage source for providing an intermediate pacing pulse voltage amplitude, the bypass circuit 156 and a second portion of the HV output circuit 160 (including at least one low-side switch 182a, 182b, or 182c) can be a predetermined output path. In other examples, the cardiac pacing output path is selected based on the pacing voltage amplitude and a programmed pacing electrode vector, which can be a coil-to-coil pacing electrode vector between the coil electrodes 24 and 26, for example, such as Figure 1A as shown in .
[0162] It should be understood that, depending on the example, certain actions or events of any of the methods described herein may be performed in a different order, may be added, combined, or omitted entirely (e.g., not all of the actions or events described are necessary to practice the method). In addition, in some examples, actions or events may be performed simultaneously, for example, through multi-threaded processing, interrupt processing, or multiple processors, rather than sequentially. In addition, for the purpose of clarity, although certain aspects of the present disclosure are described as being performed by a single circuit or unit, it should be understood that the techniques of the present disclosure may be performed by a combination of units or circuits associated with, for example, a medical device.
[0163] In one or more examples, the functions described may be implemented in hardware, software, firmware, or any combination thereof. If implemented in software, the functions may be stored as one or more instructions or codes on a computer-readable medium and executed by a hardware-based processing unit. A computer-readable medium may include a computer-readable storage medium, which corresponds to a tangible medium, such as a data storage medium (e.g., RAM, ROM, EEPROM, flash memory, or any other medium that can be used to store desired program code in the form of instructions or data structures and can be accessed by a computer).
[0164] Instructions may be executed by one or more processors, such as one or more digital signal processors (DSPs), general purpose microprocessors, application specific integrated circuits (ASICs), field programmable logic arrays (FPLAs), or other equivalent integrated or discrete logic circuits. Thus, the term "processor" as used herein may refer to any of the foregoing structures or any other structure suitable for implementing the techniques described herein. Additionally, these techniques may be fully implemented in one or more circuits or logic elements.
[0165] Therefore, medical devices have been presented in the foregoing description with reference to specific examples. It should be understood that the various aspects disclosed herein may be combined in combinations different from the specific combinations presented in the drawings. It should be understood that various modifications may be made to the referenced examples without departing from the scope of the present disclosure and the following claims.
Claims
1. A medical device comprising a therapy delivery circuit, the medical device comprising: A high voltage treatment circuit, the high voltage treatment circuit comprising: a high voltage capacitor capable of being charged to a shock voltage amplitude; a high voltage charging circuit configured to charge the high voltage capacitor to the shock voltage amplitude to generate a cardioversion / defibrillation shock pulse; and a high voltage output circuit, the high voltage output circuit comprising a first portion configured to couple the high voltage capacitor to a first electrode terminal and a second portion configured to couple the high voltage capacitor to a second electrode terminal, the first portion and the second portion being used to deliver the cardioversion / defibrillation shock pulse; a cardiac pacing voltage source configured to generate a cardiac pacing pulse signal having a pacing voltage amplitude less than the shock voltage amplitude; and A bypass circuit is configured to couple the cardiac pacing voltage source to a cardiac pacing output path, wherein the cardiac pacing output path excludes the first portion of the high voltage output circuit and includes the second portion of the high voltage output circuit to deliver the cardiac pacing pulse signal via the first electrode terminal and the second electrode terminal.
2. The medical device according to claim 1, further comprising: a sensing circuit configured to sense at least one cardiac signal; and a control circuit in communication with the sensing circuit and the therapy delivery circuit, the control circuit being configured to: determining a need for cardiac pacing based on the at least one cardiac signal; as well as In response to determining the need for cardiac pacing, the therapy delivery circuit is controlled to deliver the cardiac pacing pulse signal by enabling the bypass circuit to couple the cardiac pacing voltage source to the cardiac pacing output path.
3. The medical device according to any one of claims 1 to 2, wherein: The first part of the high voltage output circuit includes: a first high operating current switching device located between the first electrode terminal and a positive terminal of the high voltage capacitor; and a second high operating current switching device located between the second electrode terminal and the positive terminal of the high voltage capacitor; and The second part of the high voltage output circuit includes: a third switching device located between the first electrode terminal and a negative terminal of the high voltage capacitor; and a fourth switching device disposed between the second electrode terminal and the negative terminal of the high voltage capacitor; and The bypass circuit is configured to couple the cardiac pacing voltage source to the cardiac pacing output path, which excludes the first portion of the high voltage output circuit including the first switching device and the second switching device.
4. The medical device according to any one of claims 2 to 3, wherein the bypass circuit comprises at least one bypass switching device; and The control circuit is further configured to enable the bypass circuit by controlling the at least one bypass switch device to conduct the cardiac pacing pulse signal to the cardiac pacing output path.
5. The medical device according to any one of claims 2 to 4, wherein: The bypass circuit includes a first channel and a second channel, the first channel includes at least a first switching device, the second channel includes at least a second switching device; and The control circuit is configured to selectively enable the first switch device of the first channel or the second switch device of the second channel to conduct the cardiac pacing pulse signal to one of the first electrode terminal or the second electrode terminal, respectively, thereby bypassing the first portion of the high voltage output circuit.
6. The medical device according to any one of claims 1 to 5, wherein: The high voltage charging circuit is configured to generate a rail voltage by charging the high voltage capacitor to a voltage less than the shock voltage magnitude; The cardiac pacing voltage source further includes a voltage regulator configured to receive the rail voltage and generate the cardiac pacing pulse signal as a voltage regulated output signal; and The bypass circuit is configured to couple the voltage regulator to the cardiac pacing output path when enabled.
7. The medical device according to any one of claims 1 to 5, wherein: The cardiac pacing voltage source further comprises at least one charge pump for generating the cardiac pacing pulse signal; and The bypass circuit is configured to couple the cardiac pacing voltage source to the cardiac pacing output path by coupling the at least one charge pump to the cardiac pacing output path.
8. The medical device according to any one of claims 1 to 7, wherein: The cardiac pacing voltage source further comprises: a first voltage source configured to generate a first cardiac pacing pulse having a first maximum voltage amplitude up to a first range of pacing pulse voltage amplitudes; and a second voltage source configured to generate a second cardiac pacing pulse signal having a second maximum voltage amplitude up to a second range of pacing pulse voltage amplitudes, the second maximum voltage amplitude being greater than the first maximum voltage amplitude; and The bypass circuit is configured to couple the cardiac pacing voltage source of the therapy delivery circuit to the cardiac pacing output path by selectively coupling one of the first voltage source or the second voltage source to the cardiac pacing output path.
9. The medical device according to claim 8, wherein: The first voltage source comprises: a low voltage capacitor capable of charging to the first maximum voltage of the first range of pacing pulse voltage amplitudes; and a low voltage charging circuit configured to charge the low voltage capacitor to the first maximum voltage amplitude up to the first range of pacing pulse voltage amplitudes; and When the first voltage source is selected for delivering the first cardiac pacing pulse signal, the bypass circuit is configured to selectively couple the first voltage source of the cardiac pacing voltage source to the cardiac pacing output by coupling the low voltage capacitor to the cardiac pacing output path.
10. The medical device according to any one of claims 8 to 9, wherein: The bypass circuit comprises: a first channel including a first switching device and a second switching device, the second switching device coupled to the first electrode terminal; and a second channel including a third switching device and a fourth switching device, the fourth switching device coupled to the second electrode terminal; and The control circuit is further configured to: Establishing cardiac pacing pulse voltage amplitude; comparing the cardiac pacing pulse voltage amplitude to the first range of pacing pulse voltage amplitudes and the second range of pacing pulse voltage amplitudes; selecting one of the first voltage source and the second voltage source based on the cardiac pacing pulse voltage amplitude falling within one of a corresponding first range of pacing pulse voltage amplitudes and a second range of pacing pulse voltage amplitudes, responsive to selecting the first voltage source, enabling one of the second switch device of the first channel or the fourth switch device of the second channel to conduct the first cardiac pacing voltage signal to a respective one of the first terminal or the second terminal; and In response to selecting the second voltage source, enabling one of the following: (a) the first switching device and the second switching device of the first channel, or (b) the third switch device and the fourth switch device of the second channel To conduct the second cardiac pacing voltage signal to a corresponding one of the first electrode terminal or the second electrode terminal.
11. The medical device according to any one of claims 8 to 10, wherein the second voltage source comprises a voltage regulator or one of a series of at least two charge pumps.
12. The medical device according to any one of claims 2 to 11, wherein: The control circuit is further configured to detect a tachyarrhythmia based on the at least one sensed cardiac signal; and In response to the control circuit detecting the tachyarrhythmia, the high voltage therapy circuit is further configured to: charging the high voltage charging circuit to the shock voltage amplitude to generate the cardioversion / defibrillation shock pulse; and The first portion and the second portion of the high voltage output circuit are enabled to deliver the cardioversion / defibrillation shock pulse.
13. A medical device according to any one of claims 1 to 12, wherein the first electrode terminal is capable of coupling to a first high surface area electrode and the second terminal is capable of coupling to a second high surface area electrode, the first high surface area electrode and the second high surface area electrode being carried by an external cardiac lead.
